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There is a current decline in amphibian populations, wherein the emerging pathogen 
Frog Virus 3 (FV3) is believed to be a proximate cause. The conservation of frog species is 
thus important as population declines would yield drastic ecological and environmental 
impacts. Frog skin is an important interface between the frog’s external environment and 
internal milieu and is the first line of defence against pathogen insult. In mammalian models, 
the skin epithelial layer acts as an important immunological barrier against pathogens and is 
capable of recognizing and responding to pathogen-associated molecular patterns (PAMPs) 
and signal to underlying cells that a threat is present. However, the ability and role of frog 
skin epithelial cells in recognizing and responding to viral PAMPs and FV3 is unknown. To 
address this, two cell lines from the dorsal skin (Xela DS2) and ventral skin (Xela VS2) of 
the African clawed frog (Xenopus laevis) were established.  
Xela DS2 and Xela VS2 were first characterized then used as models to determine 
whether frog skin epithelial cells exhibit the ability to sense and respond to extracellular 
dsRNA. Xela DS2 and Xela VS2 cells have an epithelial-like morphology, express genes 
associated with epithelial cells, and lack beta-galactosidase associated senescence activity. 
Cells grew optimally in 70% Leibovitz’s L-15 medium supplemented with 15% fetal bovine 
serum at 26°C. Upon treatment with poly(I:C), an analogue for viral dsRNA and known type 
I interferon (IFN) inducer, Xela DS2 and Xela VS2 exhibited marked upregulation of key 
antiviral and proinflammatory transcripts, including Type I IFN and the interferon stimulated 
gene (ISG), protein kinase R (PKR). This suggests that frog skin epithelial cells may 
participate in the recognition of extracellular dsRNA and production of local inflammatory 
signals similar to mammalian models.  
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Once Xela DS2 and Xela VS2 were established as suitable models for the study of 
frog skin epithelial cell immunity, they were utilized to better understand the FV3-frog skin 
epithelial cell interaction. Xela DS2 and Xela VS2 are permissive to FV3 infection and 
support viral replication as seen by the detection of viral transcripts and increase in viral 
particles released from infected cells over time. The loss of cellular adherence in response to 
FV3 is a characteristic cytopathic effect (CPE) in Xela DS2 and Xela VS2. Xela DS2 and 
Xela VS2 appear incapable of initiating antiviral or proinflammatory programs following 
infection with FV3 or challenge with UV-inactivated FV3, suggesting that FV3 is likely 
capable of immunoevasion in these cells. Nonetheless, pre-treatment of Xela DS2 and Xela 
VS2 with poly(I:C) followed by FV3 challenge was able to completely abrogate FV3-
induced CPE and limit viral replication. This data demonstrates that despite FV3 being well 
equipped with immunoevasive strategies and mechanisms for total shutdown of host 
macromolecular synthesis, FV3 is unable to break an antiviral state in frog skin epithelial-
like cell lines. 
Overall, Xela DS2 and Xela VS2 are currently the only known frog skin epithelial-
like cell lines capable of sensing and responding to viral PAMPs and FV3. Cell line 
properties, such as plasticity in temperature growth and response to external stimuli, 
demonstrate that they are excellent models for the in vitro study of impacts from 
environmental stressors (e.g. pathogen insult, contaminants, temperature, etc.) on frog skin 
epithelial cells. Their ability to sense and respond to extracellular stimuli will also be useful 
in further elucidating host-pathogen interactions. With the demonstration that FV3 is unable 
to break an induced antiviral state in Xela DS2 and Xela VS2, we can now begin to further 
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Chapter 1: Introduction1 
1.1. Amphibians – importance and population declines 
Over 8,000 amphibian species have been discovered to date, with ~150 new species 
discovered each year (AmphibiaWeb, 2019). Amphibians are vital to the health of 
ecosystems, acting as both prey and predator, and play an important role in invertebrate pest 
control (DuRant and Hopkins, 2008). They also participate in important environmental tasks 
such as nutrient cycling and further act as sentinels of environmental health and toxicity 
(Beard et al., 2002; Showell and Conlon, 2009). Frogs, particularly the model organism 
Xenopus laevis, have been used widely in research for understanding physiological and 
developmental processes (Kay and Peng, 1992) and for the study of human diseases, such as 
cystic fibrosis (Tucker et al., 1992). Many advancements in human health have been made by 
studying frog species, such as understanding the impact of toxic compounds on hormone 
function, or identification and isolation of skin antimicrobial peptides (AMPs) which have 
broad action against many mammalian pathogens (Hinther et al., 2011; Miyata and Ose, 
2012; Showell and Conlon, 2009; Varga et al., 2019). Amphibian species are clearly integral 
not only to sustain ecological and environmental well-being, but also in the context of being 
key models for the study of human health. 
Currently, 32.5% of global amphibian populations are categorized as vulnerable, 
endangered, or critically endangered, with 43.2% of amphibian populations experiencing 
some form of population decline (AmphibiaWeb, 2019; Stuart et al., 2004). Although 
amphibian population decline etiology is complex, including habitat loss, overexploitation, 
chemical contaminants, and climate change, emerging infectious diseases, such as Frog Virus 
 
1  A version of the frog skin structure has been published in Varga, J.F.A., Bui-Marinos, M.P., 
Katzenback, B.A. 2019. Frog skin innate immune defences: sensing and surviving pathogens. Front Immunol 9. 
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3 (FV3) and Batrachochytrium dendrobatidis, are believed to be the proximate cause 
(Blaustein et al., 2010a; Stuart et al., 2004; Young et al., 2001). Ranaviruses, in general, have 
been identified in at least 105 amphibian species in 25 countries, with recent evidence of 
FV3-related mass die-offs in North America (Duffus et al., 2015; Gray et al., 2007; Greer et 
al., 2005). Varying susceptibility of frog species to FV3 infection has been documented 
(Duffus et al., 2015), but key symptoms from infection include the formation of skin lesions, 
swelling, internal hemorrhaging, and induction of necrosis and liquefaction of liver, spleen, 
renal tubule, hematopoietic tissue and lymphoid tissue (Forzán et al., 2017; Miller et al., 
2007; Robert et al., 2005). FV3 infections have high death rates (80-90% mortality) in 
infected tadpoles, suggesting a predicted negative impact on amphibian numbers by 
impairing future reproductive capacity (Daszak et al., 2003). FV3 outbreaks adversely affects 
frog populations with specialized habitats due to low adaptability or populations that have 
low fecundity (Daszak et al., 2003). The rapid loss of amphibian biodiversity can yield 
drastic ecological and environmental impacts such as the collapse of predator-prey systems 
affecting food chain dynamics (Stuart et al., 2004), signalling a critical need to understand 
frog-FV3-environment interactions in order to further amphibian conservation efforts. 
1.2. Frog Virus 3 infection and transmission  
Frog Virus 3, the type species of Family Iridoviridae, Genus Ranavirus, is a large 
(~200 nm) dsDNA virus containing a 100-106 kb genome composed of 95-100 open reading 
frames (ORFs), depending on the isolate (Chinchar et al., 2011; Morrison et al., 2014). FV3 
exists as an enveloped or naked virion. The enveloped virion enters the host cell through 
receptor-mediated endocytosis via clathrin-coated pits (Chinchar et al., 2011), with recent 
studies identifying scavenger receptor-A (SR-A) in mediating FV3 entry (Fig. 1.1A) (Vo et 
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al., 2019a). The naked virion, either external (Fig. 1.1A) or after internalization (Fig. 1.1B), 
is believed to fuse with the cell membrane or nuclear membrane, respectively, and inject its 
genomic content, but this mechanism is poorly understood (Fig 1.1C) (Jancovich et al., 2015). 
FV3 uses host machinery for replication (Fig. 1.1D), starting with the production of early 
viral mRNA transcripts by host RNA polymerase II, which is further translated by host 
machinery to produce a suite of viral proteins that are believed to participate in the shutdown 
of host macromolecular synthesis and promotion of viral replication (Fig. 1.1E, F) (Jancovich 
et al., 2015). It has previously been documented that dsRNA is also produced during FV3 
replications cycles (Doherty et al., 2016) and can be detected in the intracellular space (Fig. 
1.1). After nuclear replication by viral DNA polymerase (Fig. 1.1G), FV3 dsDNA enters the 
cytosol which may then be used to undergo late viral mRNA transcript production via viral 
RNA polymerase II (Fig. 1.1H). This leads to the synthesis of viral packaging and capsid 
proteins (Fig. 1.1I) (Jancovich et al., 2015). Cytosolic DNA also polymerizes to form viral 
DNA concatemers in preparation of virion assembly. With viral DNA concatemers present in 
the cytosol, FV3 virion packaging and assembly begins upon capsid protein production (Fig. 
1.1J), however this process is not well understood. This assembly creates a crystalline array 
of active virions which may then bud out from the cell membrane, creating the presence of 
enveloped FV3 (Fig. 1.1K), wherein naked FV3 is released upon cell death (Jancovich et al., 
2015). 
A hallmark of FV3 infection, which appears to be conserved among many large 
dsDNA viruses, is its ability for the complete shutdown of host macromolecular synthesis, 
regardless if the virus is infective or inactivated through heat or UV treatment, and the 
presence of proteins which elicit immunoevasion properties (Goorha and Granoff, 1974; 
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Jancovich et al., 2015; Williams, 1996). While the ability for FV3 to selectively inhibit host 
machinery is unknown, it is believed that viral proteins may play a role in inhibition of host 
polymerases and selective translation of viral mRNA transcripts (Fig. 1.1F) (Jancovich et al., 
2015). Studies on knockout FV3 mutants for the genes 18K, 52L, 64R and viF2α showed 
reductions in viral infectivity and replication in X. laevis tadpoles (Andino Fde et al., 2015; 
Chen et al., 2011; Jacques et al., 2017). Nonetheless, the presence of viral polymerases is 
believed to not only take over host transcription and DNA replication but also be responsible 
for generating high levels of viral products that outcompete and suppress host 
macromolecular synthesis (Fig. 1.1F) (Jancovich et al., 2015). 
Much of our understanding of frog-FV3 interactions and pathogenesis derives from 
studying FV3 in the context of the African clawed frog, Xenopus laevis and represents a host 
that is relatively resistant to FV3. FV3-Infected adult X. laevis appear symptomatic (slight 
skin shedding, lethargy) for 3-4 weeks then appear asymptomatic thereafter (Robert et al., 
2007). During the symptomatic phase, FV3 infected adult X. laevis transmit infectious virus 
to adult and larval X. laevis within 3 hours of exposure through waterborne transmission 
(Robert et al., 2011).  As part of their innate immune response, X. laevis increases the total 
number of peritoneal leukocytes (PL) to fight infection, combined with FV3-induced 
proinflammatory gene expression (il-1b and tnfa) in PLs (Morales et al., 2010).  FV3 infected 
adult X. laevis mount an adaptive immune response as demonstrated by the ability to develop 
a memory CD8+ T-cell response, supported by quicker cell proliferation and FV3 clearance 
upon secondary infection (Morales and Robert, 2007). Although FV3-infected adult X. laevis 




Figure 1.1. Schematic of Frog Virus 3 infection, replication, and suppression in a susceptible host cell. (A) Cellular 
recognition of enveloped FV3 by SR-A helps to mediate cellular entry, while naked virions fuse with the cell membrane and inject 
genetic material. (B) After internalization, FV3 interacts with host nucleus and (C) injects viral DNA into the nucleus. (D) Host 
RNA polymerase II generates early viral mRNA (E) followed by the synthesis of viral proteins. (F) Select proteins are believed to 
inhibit host machinery, wherein FV3-derived RNA polymerase II generate transcripts to outcompete host translation, and viral 
DNA polymerase synthesizes viral DNA. (G) Replicated viral DNA enter host cytosolic space (H) where late viral mRNA 
synthesis allows for the synthesis of (I) viral capsid proteins. (J) Active virions are assembled which then (K) bud from the host 
membrane to propagate infection. Figure was adapted from (Janovich et al, 2015).  
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FV3 can be detected in the kidney of recovered X. laevis, suggesting a quiescent state of FV3 
that permits reactivation of viral replication when the host is immunosuppressed (Robert et 
al., 2007; Robert et al., 2014). As such, even resistant anuran hosts can play an important role 
in FV3 transmission, particularly under environmental conditions that may lead to host 
immunosuppression and FV3 reactivation.  
Upon release from infected hosts, FV3 is transmitted through the environment, either 
through direct contact (e.g. during mating), indirect contact (e.g. water borne transmission) or 
consumption of infected carcasses (Brunner et al., 2007; Schock et al., 2008). In addition to 
infected amphibians shedding FV3 into the environment, other frogs, salamanders, fish, and 
reptiles may be potential reservoirs for FV3, even if the host is not susceptible to infection, 
potentiating the transmission of FV3 to susceptible hosts (Duffus et al., 2008; Hausmann et 
al., 2015). Regardless of the transmission route, FV3 must cross either the skin epithelial 
barrier or the gut epithelial barrier. A key symptom of FV3 infection in susceptible 
developmental stages of frog species is skin shedding and the formation of skin lesions 
through epidermal cell necrosis (Forzán et al., 2017; Gray et al., 2009). It is proposed that 
loss of the skin barrier during FV3 infection allows for increased pathogen entry and 
ultimately leads to mortality in susceptible hosts, stressing the overall importance of the skin 
barrier (Chinchar et al., 2011; Varga et al., 2019). Yet, much of the innate immune properties 
of frog skin remain to be understood outside of antimicrobial peptides. 
1.3. Vertebrate skin as the first line of defence 
While the structure and certain features of skin is species dependent, the role is 
generally conserved – skin acts as a the initial protective layer between the environment and 
the host’s internal makeup (Haslam et al., 2014). Though skin composition varies across 
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species, the organization of skin layers appears consistent: there is an epithelial cell-rich 
epidermal layer, and lower fibroblastic cell-rich dermal layer (Haslam et al., 2014), wherein 
both are important in maintaining skin barrier integrity and epithelial cells are the initial 
interface between the environment and organism. 
1.3.1. Structural properties of mammalian epidermis  
The two main basic cell types that comprise the skin barrier include epithelial cells 
comprising the epidermal layer, and fibroblastic cells from connective tissue (Haslam et al., 
2014). Specifically, the surface epithelial cells serve as a physical protective barrier through 
the formation of tight junctions and adherens junctions (Niessen, 2007). Tight junctions are 
strictly localized to epithelial and endothelial cells and require integral membrane proteins 
from the claudin and occludin families for formation (Furuse et al., 1998; Furuse et al., 1993). 
Claudin-1 is expressed across all tissue types and is capable of interacting with other claudin 
types, such as claudin-3 (Coyne et al., 2003; Furuse et al., 1998). Claudin-3 has no defined 
expression profile, but claudin-3 presence has previously been identified in mucosal tissue 
and has been known to increase in expression in malignancies (Coyne et al., 2003; Hewitt et 
al., 2006). Adherens junctions require the protein cadherin to be functional and has broad 
range expression across cells including, but not limited to, epithelial cells, fibroblastic cells, 
and neuronal cells (Matsuyoshi and Imamura, 1997; Yap et al., 1997). Among these, the 
expression of cadherin-1 (E-cadherin) is known to be specific for epithelial cells (van Roy 
and Berx, 2008). Meanwhile, skin can possess mesenchyme tissue derived from epithelial 
cells which have undergone an epithelial to mesenchymal transition (EMT), characterized by 
the loss of tight junctions and adherens junctions and increased levels of vimentin filament 
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(Cano et al., 2000; Figiel et al., 2017; Kalluri and Weinberg, 2009). Nonetheless, the cellular 
junctions formed between epithelial cells is necessary for maintaining surface skin integrity.  
Structurally, mammalian cytoskeleton is composed of 3 principal structural units: 
actin microfilaments, tubulin microtubules, and intermediate filaments (Chu and Weiss, 
2002). Of these, there are 6 intermediate filaments, wherein 2 of the 6 include acidic type I 
and basic type II cytokeratins (Chu and Weiss, 2002). Pairs of cytokeratins appear to be co-
expressed in different types of epithelial cells (Chu and Weiss, 2002), wherein all 
mammalian epithelial cells possess cytokeratins for structural support (Moll et al., 1982). Of 
the type I cytokeratins, cytokeratin 19 is found in stratified squamous epithelia as well as 
simple epithelia (Chu and Weiss, 2002). Cytokeratin 14 (type I) and cytokeratin 5 (type II) 
are a cytokeratin pair which localizes in basal keratinocytes of the epidermis (Chu and Weiss, 
2002). Expression and identification of cytokeratins is specific for epithelium and not found 
in connective tissue (Chu and Weiss, 2002). Yet in connective tissue, fibroblast cells 
demonstrate a high level of collagen synthesis as well as the intermediate filament vimentin 
as part of its cytoskeletal structure (Brewer, 1967; Franke et al., 1978). Structurally distinct 
collagen types are distributed in a specific fashion; collagen type I and collagen type III were 
found to be distributed and co-regulated in interstitial connective tissues while type II 
collagen is exclusively found in cartilage (Raghow and Thompson, 1989). In addition to 
participating in cytoskeletal structure in fibroblast cells, collagen is an important component 
in extracellular matrix formation (Ricard-Blum, 2011). Distinct cell types express unique 
genes necessary for its overall function, wherein the presence of cytokeratins is a hallmark of 
epithelial cell identification. 
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1.3.2. Frog epidermis  
Frog skin supports vital physiological functions including, but not limited to, 
respiration, ion regulation, water transport, predator defence and immune function (Larsen 
and Ramløv, 2013; Lillywhite, 2006; Toledo and Jared, 1995). Mucosal glands within frog 
skin secrete mucus to maintain skin moisture, permeability and elasticity, all of which are 
necessary for homeostasis (Larsen and Ramløv, 2013; Lillywhite, 2006; Lillywhite and Licht, 
1975), while also functioning in pathogen trapping and removal (Cone, 2009; Stannard and 
O'Callaghan, 2006). In addition, frogs have evolved a specialized glandular network beneath 
the skin surface that synthesize and secrete a plethora of antimicrobial and toxic substances, 
thus aiding in the defence against pathogens and predators (Toledo and Jared, 1995). Yet 
frog skin is particularly vulnerable to cutaneous injury due to the relatively thin and 
permeable nature of the organ – characteristics necessary to support many of the 
aforementioned physiological processes. Thus, frog skin is an important first line of defence 
against harmful agents in the environment. 
Frog skin is composed of epidermal and dermal layers, with each layer predominantly 
consisting of epithelial and fibroblastic cells, respectively (Haslam et al., 2014; Villaro et al., 
1998). While it is presumed that features of mammalian epithelial and fibroblast cells are 
conserved in amphibians, the mucosal nature of frog skin epithelium suggests that frog skin 
epithelial and fibroblast cells may differ compared to those in non-mucosal skin tissues. For 
example, while human and mouse skin epidermal cells generally do not produce collagen, 
epithelial cells from human, mouse, and chick mucosal tissues (i.e. gut, lung, eye) do 
produce collagen (Birkedal-Hansen et al., 1982; Haslam et al., 2014; Hayashi et al., 1988; 
Ohji et al., 1994). Although collagen has been identified in whole frog skin (Li et al., 2004; 
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Purna Sai and Babu, 2001), the exact cellular source is unknown. Furthermore, frog skin is 
unique in that although it acts as a direct interface to the environment like skin in other 
organisms, it is also a mucosal tissue like from the gut or lung mucosa (Haslam et al., 2014). 
As such, this must be kept into consideration if making comparisons to mammalian skin, 
which is non-mucosal; comparisons to mammalian mucosal tissue may be more appropriate 
in instances.  
The presence of cellular junctions is a key hallmark of epithelial cells in mammalian 
models, a feature which appears conserved for amphibian species (Farquhar and Palade, 
1963, 1965). Tight junction proteins are detected as early as the gastrulation stage and persist 
until full development (Farquhar and Palade, 1965). The presence of tight junction claudin-1 
proteins is crucial during gastrulation in X. laevis embryos (Chang et al., 2010), but general 
observations of tight junction proteins in adult frogs are lacking. In early larvae, tripartite 
junctional complexes of tight junction, adherens junction, and desmosomes are observed, 
wherein these complexes appear to lose significant contribution from adherens junctions in 
larvae approaching metamorphosis and in adult frogs (Farquhar and Palade, 1965). 
Nonetheless, strong expression of adherens-dependent cadherin protein has been detected in 
adult X. laevis skin (Levi et al., 1991). While the presence and role of gap junctions and 
desmosomes have been reported in the skin of other vertebrates, the observation of these 
junctions in frogs has been limited to frog embryos undergoing development, or 
identification in adult frogs (Munoz et al., 2012; Shahin and Blankemeyer, 1989; Suhrbier 
and Garrod, 1986; Warner, 1985). Though all cellular junctions have been identified in frogs 
at different developmental stages, it is important to note that these studies have been limited 
to X. laevis and R. pipiens species and thus may not necessarily be representative of all frogs. 
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Collectively, epithelial cell junctions allow for a continuous epithelial network that is 
relatively closed to the external environment while remaining open to the basal collagenous-
rich dermal layers. As such, maintenance of epithelial cellular junctions is important for 
barrier integrity, and thus pathogen defence, particularly considering the relatively thin 
epidermal layer in frogs.  
1.4. Cellular pathogen recognition and defense  
A recent phenomenon which has been garnering attention is the participation of non-
immune cells in recognizing and responding to external stimuli, and further downstream 
signaling to help initiate an immune response. These include local cell populations around a 
site of injury or infection, such as epithelial cells, acting as a more immediate responder than 
relying on the systemic recruitment of immune cells. While the immune role of mammalian 
epithelial cells, of epidermal and mucosal origin, has been elucidated, efforts in amphibian 
models are lacking. 
1.4.1. Mammalian cellular innate immunity 
Mammalian cells produce germ-line encoded pattern recognition receptors (PRRs) 
that can bind pathogen-associated molecular patterns (PAMPs). Viruses may either contain 
or produce several viral PAMPs in their replicative cycle such as nucleic acids: double-
stranded ribonucleic acid (dsRNA), single-stranded ribonucleic acid (ssRNA), double-
stranded deoxyribonucleic acid (dsDNA) and single-stranded deoxyribonucleic acid (ssDNA) 
(Bartenschlager et al., 2010; Buller and Palumbo, 1991; Chinchar, 2002; Doherty et al., 
2016). Viral nucleic acids are released extracellularly upon host cell lysis during infection 
where they can be recognized by nearby host cells. This recognition may be performed by 





Figure 1.2. Cellular recognition and antiviral response to viral nucleic acids. (A) Detection of exogenous viral nucleic acids or 
endocytosis-internalization into the host cell, mediated by SRs in the case of dsRNA. (B) Viral nucleic acids are recognized by 
endosomal TLRs upon endosomal fusion, or free nucleic acids sensed by cytosolic receptors. (C) Regardless of PRR engagement, 
intracellular signaling pathways converges to activate IRF3/3, NF-κB and AP-1 transcription factors, leading to nuclear 
translocation and the up-regulation in gene expressions and protein synthesis of (D) proinflammatory cytokines, chemokines, and 
the inhibitor of NF-κB (IκB) and (E) antiviral molecules. 
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responsible for trafficking substrates to endosomes (Fig. 1.2A) (Murshid et al., 2015; 
Yoneyama and Fujita, 2010). Once trafficked to endosomes, viral PAMPs can be sensed by 
toll-like receptors (TLRs) (Fig. 1.2B) wherein TLR3 senses dsRNA, TLR 7 and TLR 8 sense 
ssRNA, and TLR9 senses dsDNA (Kawasaki and Kawai, 2014; Yoneyama and Fujita, 2010). 
Free viral nucleic acids may also be present in the cytosol, through viral delivery or produced 
during the viral replicative cycle, and can be sensed by cytosolic PRRs (Fig. 1.2B). Cytosolic 
dsRNA is recognized by protein kinase R (PKR) and the RIG-I-like receptors (RLRs) RIG-I 
and MDA5 (Wilkins and Gale, 2010; Yoneyama and Fujita, 2010; Zhou et al., 2014). 
Furthermore, dsDNA is also a viral PAMP commonly found in dsDNA viruses, such as FV3, 
and can be sensed by cytoplasmic DNA sensors such as the cGAS-STING system (Fig. 1.2B) 
(Diner et al., 2013), among others. Recognition of viral nucleic acids by these PRRs leads to 
the initial homodimerization of interferon regulatory factor (IRF) 3 to create the IRF3/3 
transcription factor (Bonjardim et al., 2009; Ysebrant de Lendonck et al., 2014), alongside 
the activation of NF-κB and AP-1 transcription factors (Fig. 1.2C) (De Bosscher et al., 2003). 
NF-kB and AP-1 induce transcription regulation of proinflammatory cytokines and 
chemokines such as IL-1β, TNFα, IL-8, and IκB (Fig. 1.2E) (De Bosscher et al., 2003). 
Meanwhile, the initial activation of Type I IFN gene expression requires the recognition of 
NF-κB, AP-1 and IRF3/3 transcription factors (Fig. 1.2D) (Bonjardim et al., 2009; Ysebrant 
de Lendonck et al., 2014). These proteins are responsible for initiating antiviral and 
proinflammatory activities in the host. 
Innate immune responses to viral pathogens are primarily mediated by a class of 
cytokines called interferons (IFN), important antiviral cytokines involved in inducing an 





Figure 1.3. Induction of interferon-stimulated genes upon Type I IFN recognition. Cellular recognition of secreted Type I IFN 
by its cognate receptor, IFNAR1/2, leads to the phosphorylation of STAT1 and STAT2 via JAK proteins, which together create a 
tripartite complex with IRF9. The formation of this complex yields the transcription factor interferon-stimulated gene factor 3 
(ISGF3). ISGF3 then binds to ISREs and allows for the induction and subsequent synthesis of a number of ISGs, such as Mx 




of IFNs include Type I IFN, Type II IFN, and Type III IFN with Type I and Type III IFNs 
possessing functionally similar antiviral effects (Vilcek, 2003). Notably, while Type I IFN 
appears to act globally, Type III IFN targets mucosal epithelial cells in a mammalian model 
(Wack et al., 2015). Once produced and secreted, IFNs can act in an autocrine or paracrine 
fashion by binding to IFN receptors, activating Janus family kinases (JAK) and signal 
transducer and activator of transcription (STAT) proteins (Fink and Grandvaux, 2013). In the 
case of Type I IFN responses, JAK1 and Tyk2 JAK proteins phosphorylate STAT1 and 
STAT2 proteins, which then form a heterotrimer with IRF9 (Fig. 1.3)  (Fink and Grandvaux, 
2013). This heterotrimer complex is referred to as the interferon-stimulated gene factor 3 
(ISGF3) and is the transcription factor that binds to interferon stimulated response elements 
(ISREs) to upregulate interferon-stimulated genes (ISGs; Fig. 1.3) (Fink and Grandvaux, 
2013; Hayes and Chayama, 2017). Over 1000 ISGs have been identified (Fig. 1.3), wherein 
previous studies found less than a 2-fold change in ISG induction for over 75% of these (Der 
et al., 1998).  
Antiviral effectors, such as (2’-5’)-oligoadenylate synthetase (OAS), PKR, and 
interferon-inducible GTPase myxovirus-resistance proteins (Mx) (Fig. 1.3), are integral to 
limiting viral replication and viral  dissemination (Alsharifi et al., 2008; Schoggins and Rice, 
2011; Sen and Ransohoff, 1993). OAS specifically binds cytosolic viral dsRNA and, through 
a combination of effects, degrades both viral and host cellular ssRNA, effectively 
suppressing viral infection (Silverman, 2007). PKR is activated mainly by the presence of 
dsRNA and its key antiviral effect is to suppress viral replication through translational 
inhibition (Williams, 1999). Mx genes are divided into two lineages: nuclear protein Mx1 
and cytoplasmic protein Mx2 (Haller et al., 2015; Pilla-Moffett et al., 2016). Functionally, 
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Mx1 inhibits primary transcription occurring in the nucleus performed by viral nucleocapsid-
associated viral polymerase, while Mx2 inhibits viruses which replicate exclusively in the 
cytoplasm (Haller and Kochs, 2011; Pilla-Moffett et al., 2016). IRF7 is also an ISG and, once 
synthesized, can heterodimerize with IRF3 to generate the IRF3/7 transcription factor to 
further enhance the expression of Type I IFN and promote cellular antiviral responses 
(Martins et al., 2015; Ysebrant de Lendonck et al., 2014). Overall, vertebrates rely on the 
IFN response to elicit antiviral programs to limit and/or eliminate viral infections. A common 
method used to study Type I IFN responses in cells is through treatment with polyinosinic-
polycytidylic acid [poly(I:C)], a viral dsRNA analogue that is also recognized by surface SR-
As present on some cell types and trafficked to endosomal TLR3 (Martins et al., 2015; 
Murshid et al., 2015) to elicit the same set of antiviral mechanisms.  
The stimulation of viral nucleic acid sensors also results in the direct or ISG-mediated 
activation of NF-κB, turning on proinflammatory programs (Alexopoulou et al., 2001; 
Zamanian-Daryoush et al., 2000). Proinflammatory cytokines, such as TNF and IL-1β, and 
chemokines, such as IL-8, are key mediators of host inflammatory responses to infection 
(Dinarello, 2000). TNF is expressed by many cell types and binds to the TNF receptor and 
yields three key cell signaling events: activation of mitogen-activated protein kinase pathway, 
induction of NF-κB, and induction of cell death signaling (Locksley et al., 2001; Zelova and 
Hosek, 2013). TNF can act on other cell types, including epithelial cells, to activate NF-κB 
and can thereby induce the gene expression of IL-1 (Dinarello, 1996; Dolcet et al., 2005). 
Alternatively, transcriptional activation of IL-1 can occur in response to engagement of PRRs 
and downstream activation of NF- κB (Lawrence, 2009). In mammals, IL-1 protein possesses 
an interleukin-1 converting (ICE) cleavage site, leading to production of IL-1β. In fish and 
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frogs, a definitive ICE cleavage site is not present in the IL-1 protein and the exact 
mechanism of how IL-1β is produced from the IL-1 protein is unclear (Covello et al., 2009; 
Jelaso et al., 1998; Liu et al., 2012). Lastly, the transcription and translation of IL-8 
following TLR engagement is essential for inducing chemotaxis of neutrophils to the site of 
infection and enhancement of their phagocytic capacity (Baggiolini et al., 1989). The 
combined effects of TNF, IL-1 β, and IL-8 facilitate a proinflammatory response to an array 
of pathogens. While epithelial cells act as an important physical barrier to pathogen entry, 
they are also essential in viral detection and activation of underlying innate immune cells 
through the induction of cellular antiviral mechanisms (Dai et al., 2008; Kopfnagel et al., 
2011; Tohyama et al., 2005).  
1.4.2. Frog cellular innate immunity and understanding FV3 pathogenesis 
through X. laevis 
Despite extensive studies showing that amphibian skin is vital to survival, relatively 
little focus has been placed on examining the role of frog skin epithelium in sensing and 
responding external stimuli, such as pathogen attack. This focus is paramount since mucosal 
epithelia are more prone to pathogen attack, such as that seen in mammalian lung and gut 
epithelium (Kim et al., 1998; Plotkowski et al., 1993; Ringø et al., 2010; Sperandio et al., 
2015). While the ability for mammalian epithelial cells to sense and respond to viral nucleic 
acids has been documented (Dai et al., 2008; Kopfnagel et al., 2011; Tohyama et al., 2005), 
the observation of this in frog skin epithelial cells is lacking. While the majority of X. laevis-
FV3 research has bypassed the skin barrier via intraperitoneal injection of virus into the host 
(Jacques et al., 2017; Koubourli et al., 2017; Morales et al., 2010; Morales and Robert, 2007), 
a couple of recent studies in X. laevis have investigated the role of Type I IFN and Type III 
IFN mediated antiviral response in adult and tadpole X. laevis skin during FV3 infection 
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(Wendel et al., 2017; Wendel et al., 2018). Subcutaneous administration of Type I IFN or 
Type III IFN in X. laevis tadpoles, which are highly susceptible to FV3, offered short-term 
protection against FV3 infection, combined with induced expression of antiviral genes in the 
skin (Wendel et al., 2017). Furthermore, it appears that Type I IFN and Type III IFN 
responses may play an integral role in the antiviral response in X. laevis skin in adult frogs 
and tadpoles, respectively (Wendel et al., 2017; Wendel et al., 2018). However, the 
contribution of frog skin epithelial cells in mediating these antiviral responses remains 
unknown due to the inherent complexity of whole skin tissue, requiring further introspection 
into the interaction between FV3 and isolated frog epithelial cells.  
1.5.  Research scope, objectives, and hypotheses 
While extensive studies have been conducted to unveil FV3 pathogenicity and host 
immune response at the animal level, particularly in X. laevis, the role of skin epithelial cells 
in sensing and responding to pathogens is not well understood. Furthermore, examination of 
FV3 infection of frog skin epithelial cells remains to be elucidated. It is important to 
investigate the interaction between frog skin epithelial cells and FV3 as the skin is the first 
barrier of defense, and one of the modes of FV3 transmission is known to occur through 
direct skin contact (Lesbarreres et al., 2012). Elucidation of this interaction will prove to be 
insightful when further exploring how frog skin epithelial cells, whether through natural or 
induced mechanisms, may aid in attempting to limit viral infection and spread. In part, this 
remains unexplored due to a lack of model systems available to actively study the frog skin 
epithelial cell-FV3 interaction.  
I investigated two main objectives for my master’s thesis to address this knowledge gap. 
Chapter 2 focused on the establishment, development and characterization of novel X. laevis 
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dorsal and ventral skin epithelial-like cell lines, Xela DS2 and Xela VS2, and their capacity 
to recognize the extracellular viral dsRNA analogue, poly(I:C). I hypothesize that Xela DS2 
and Xela VS2 are epithelial in nature and can recognize and respond to extracellular 
poly(I:C). Upon establishing Xela DS2 and Xela VS2 as suitable models for studying frog 
skin epithelial cell antiviral responses, Chapter 3 investigated Xela DS2 and Xela VS2 
susceptibility to FV3, their response to FV3 infection, and whether poly(I:C) pre-treatment 
could induce a functional antiviral state that confers resistance to FV3 infection. Here, I 
hypothesize that Xela DS2 and Xela VS2 are permissive to FV3 infection and replication, 
wherein poly(I:C) pre-treatment would confer protective properties due to initial 





2. Chapter 2: Xela DS2 and Xela VS2: two novel skin epithelial-
like cell lines from adult African clawed frog (Xenopus laevis) 
and their role in sensing extracellular viral dsRNA 
2.1. Introduction 
Amphibian skin is a unique organ that participates in barrier function as well as key 
physiological processes necessary for survival. Although dependent on the species, 
physiological functions may include osmoregulation, respiration, ion transport, 
thermoregulation and more (Haslam et al., 2014; Lillywhite, 2006). The skin epithelium 
serves as a direct interface between an amphibian’s internal milieu and external environment, 
facing constant exposure to changing temperatures, environmental pollutants, and acting as 
the first line of defence against pathogens (Stuart et al., 2004). Accordingly, skin integrity 
and barrier function must be continuously maintained and reinforced to limit the effects of 
subjected environmental insult, including pathogens.  
Recent evidence in murine and human models suggest that epithelial cells are more 
than just bystanders, playing an active role in pathogen sensing and downstream signalling to 
immune cells (Braff et al., 2005; Hamel et al., 2015; Pasparakis et al., 2014). Epithelial cells 
express a number of pattern recognition receptors (PRRs) that sense pathogen-associated 
molecular patterns (PAMPs), leading to the activation of key transcription factors (IRF3/3, 
NF-B, AP-1) depending on the PAMP recognized and, mediates the transcriptional 
regulation of key antiviral and proinflammatory cytokines and chemokines in response to a 
range of microbes (Artis, 2008; De Bosscher et al., 2003; Ghosh et al., 1998; Tosi, 2005). In 
the case of viral-associated double-stranded RNA (dsRNA), extracellular dsRNA is 
trafficked to endosomal TLR3 by SR-As while intracellular dsRNA is recognized by 
cytosolic RIG-I or MDA5. Recognition of dsRNA by endosomal or cytosolic dsRNA sensors 
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lead to the activation and homodimerization of IRF3 to initiate host cell antiviral programs 
through the initial expression of type I and/or type III interferons (IFN). Secreted type I or 
type III IFNs can then act in an autocrine or paracrine fashion through their cognate IFN 
receptors (IFNARs) on the infected or neighbouring healthy cells. Binding of IFNAR1/2 
leads to the activation of the transcription factor complex ISGF3, comprised of 
STAT1/STAT2 and IRF9, and binds interferon stimulated response elements (ISREs) to 
regulate the expression of interferon stimulated genes (ISGs), many which encode for the 
proteins necessary for mediating antiviral programs in the host (Fink and Grandvaux, 2013; 
Hayes and Chayama, 2017; Schoggins and Rice, 2011) and includes IRF7, a transcription 
factor that can heterodimerize with IRF3 to further bolster the induction of type I IFNs in a 
positive feedback loop (Bonjardim et al., 2009; Ysebrant de Lendonck et al., 2014).. 
Despite the documented roles of skin epithelial cells in pathogen sensing and 
initiation of proinflammatory and antiviral responses in mouse and human models (Gomez et 
al., 2013; Nestle et al., 2009), very little is known regarding whether frog skin epithelial cells 
function in a similar fashion. Among frog species studied, the African clawed frog (Xenopus 
laevis) has been established as a model system to investigate the host-pathogen interactions 
and amphibian immunity (Gantress et al., 2003; Ramsey et al., 2010). However, the 
contribution of isolated skin epithelial cells to amphibian antiviral immunity remains limited. 
It is critical to dissect the potential individual role(s) of frog skin epithelial cells in regard to 
recognizing and responding to viral-associated molecular patterns to improve our 
understanding of the skin epithelial cell antiviral mechanisms.  
Since dsRNA is produced by the majority of viruses at some point during their 
replicative life cycle (Weber et al., 2006), addition of poly(I:C), a viral dsRNA analogue, 
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may approximate extracellular dsRNA potentially released from infected cells due to cell 
lysis and illustrate the potential of frog skin epithelial cells to recognize viral dsRNA in vivo. 
In this chapter, I hypothesized that X. laevis skin epithelial cells are capable of recognizing 
and responding to poly(I:C), a mixture of synthetic dsRNA of various lengths and a known 
inducer of Type I IFN (Longhi et al., 2009; Poynter and DeWitte-Orr, 2018). Therefore, the 
first objective of this chapter was to generate X. laevis skin epithelial cell lines for use as a 
model system to study host-pathogen interactions. The second objective was to determine 
whether these cell lines were capable of recognizing and responding to exogenous poly(I:C) 
and characterizing the potential response. Herein, I report on the generation and 
establishment of two skin epithelial-like cell lines from X. laevis dorsal and ventral skin, 
named Xela DS2 and Xela VS2, respectively, their optimal growth conditions, and 
morphological and molecular characterization. Furthermore, I assessed the expressions of 
key antiviral genes, proinflammatory cytokines, and chemokine in response to treatment with 
poly(I:C) over time.  
2.2. Methods 
2.2.1. Frogs 
Tissues from female African clawed frogs (Xenopus laevis) were kindly donated by 
Dr. Mungo Marsden (University of Waterloo, Waterloo, ON). Dr. M. Marsden purchased X. 
laevis from Nasco (Fort Atkinson, Wisconsin, USA) and these frogs were previously used in 
a breeding colony. Frogs were fed ad libitum with Xenopus food pellets (Boreal Science) and 
housed in opaque tanks filled with well water that was replaced twice a week. Frogs were 
kept at 22oC in the Aquatic Facility of the Biology building, University of Waterloo. Prior to 
tissue extraction, frogs were euthanized by immersion in a solution of benzocaine (300 mg/L, 
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initially dissolved in 1 mL 100% ethanol). The frogs were maintained according to the 
guidelines of the University of Waterloo Animal Care Committee and the Canadian Council 
of Animal Care (CCAC-Canada). 
2.2.2. Media  
Leibovitz’s L-15 medium (HyClone) was diluted to 70% with cell culture water 
(Lonza) to adjust for the osmolarity of amphibian cells and will herein be referred to as AL-
15. During initial establishment of cell tissue explant cultures, media was comprised of AL-
15 supplemented with 20% fetal bovine serum (FBS; HyClone), 200 U/mL penicillin 
(HyClone), 200 μg/mL streptomycin (HyClone), 50 μg/mL gentamicin sulfate (HyClone) 
and 1 μg/mL amphotericin B (HyClone), herein referred to as establishment media. Once the 
primary cultures were established and in the early passage stage (passage 4-6), the 
continuous skin cell cultures were maintained using AL-15 medium supplemented with 15% 
FBS, 100 U/mL penicillin, 100 μg/mL streptomycin, and 50 μg/mL gentamicin sulfate. From 
passage 10 onwards, cells were maintained in AL-15 media supplemented with 15% FBS, 
without antibiotics, and will be referred to as complete medium. Amphibian phosphate-
buffered saline (APBS) was prepared by diluting Dulbecco’s phosphate-buffered saline 
(DPBS; Lonza) to 70% of the original salt concentration with cell culture water and 0.25% 
Trypsin-EDTA (HyClone) was also diluted to 70% original concentration with cell culture 
water.  
2.2.3. Generation and establishment of continuous skin cultures 
Dorsal and ventral skin were dissected from euthanized X. laevis under sterile 
conditions and placed in individual petri dishes containing APBS supplemented with 200 
U/mL penicillin, 200 μg/mL streptomycin, and 50 μg/mL gentamicin sulfate. Tissues were 
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cut into small pieces with a scalpel and washed twice in APBS containing antibiotics prior to 
placing 4-6 tissue pieces into a 25 cm2 plug-seal tissue culture treated flask (BioLite, Thermo 
Scientific) containing 1.5 mL establishment medium to cover the tissue pieces. Primary 
tissue explant cultures were maintained at 26°C, in the absence of additional CO2. Medium 
was changed twice a week for the first three weeks using establishment media, and every 5-7 
days afterwards using complete medium. Tissue culture explants were monitored for cell 
outgrowth. Once tissue explant cultures exhibited significant cell growth, adherent cells were 
collected by removing complete medium and washing cell cultures with 1× APBS prior to 
the addition of Trypsin-EDTA. Upon cell detachment, medium containing 20% FBS was 
added and the cells were sub-cultured into fresh 25 cm2 plug-seal tissue culture flasks. Two 
continuous cell cultures were generated from these primary tissue explant cultures, named 
Xela DS2 and Xela VS2 for dorsal and ventral skin, respectively.  
2.2.4. Cell culture maintenance 
Early cell cultures were passed every 7 to 10 days at a 1:2 split. Once established 
(>passage 25 for Xela DS2, >passage 30 for Xela VS2), Xela DS2 and Xela VS2 continuous 
skin cell cultures were maintained in 75 cm2 plug-seal tissue-culture treated flasks at 26°C in 
complete medium without antibiotics. Upon becoming confluent, usually every 3-4 days, 
cells were split. Briefly, medium was removed from the flask and cells washed with 3-5 mL 
of APBS. Following removal of the APBS, 2 mL of trypsin-EDTA was added to detach cells 
from the cell culture vessel. Cell detachment was monitored and complete medium was 
immediately added following cell detachment to inactivate trypsin. Cells were sub-cultured 
1:4 into flasks containing 10 mL of fresh complete medium. Collected cells were used for 
setting up experiments, wherein a plating efficiency for cell seeding of 79% and 83% was 
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considered for Xela DS2 and Xela VS2 respectively. The reported cell numbers used in the 
experiments described below were all corrected for these plating efficiency differences. Cell 
morphology was monitored over successive passages by capturing phase-contrast images 
using a Nikon Eclipse TSX-100 microscope (taken at 100× magnification) fitted with a color 
camera and Picture Project software during early passages and with a Zeiss AxioVert-A1 
microscope (taken at 200× magnification) fitted with an Axiocam 503 color camera and Zen 
2.0 Lite software during later passages.  
2.2.5. Cryopreservation 
After harvest from tissue culture vessels, Xela DS2 or Xela VS2 cells were 
centrifuged at 500 × g for 5 min to pellet cells. The supernatant was removed and cells were 
resuspended to approximately 2 × 106 million cells per mL in chilled complete medium 
containing 10% DMSO (Fisher Scientific). One mL of cell suspension was aliquotted into 
individual cryogenic tubes (Nunc) and vials placed in a Mr. Frosty freezing container 
(Thermo Scientific) at -80°C overnight prior to long-term storage in liquid nitrogen. 
2.2.6. Hematoxylin-Eosin (H&E) staining  
Xela DS2 (passage 74) and Xela VS2 (passage 75) cells were seeded in 6-well plates 
(BioLite, Thermo Scientific) at cell densities of 300,000 cells/well in 1 mL of complete 
medium and allowed to adhere overnight at 26°C. The following day, media was removed 
from the wells and cells were fixed to the tissue culture plate by adding 70% ethanol for 2 
min with gentle agitation. The ethanol was aspirated and residual ethanol was allowed to 
evaporate before cells were rinsed with 1 mL of Scott’s Tap Water for 30 s, with agitation. 
Cells were stained with Hematoxylin Gill 3 solution (VWR) for 5 min with agitation and 
washed with six exchanges of 1 mL Scott’s Tap Water (240 mM NaHCO3, 135 mM MgSO4, 
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pH 8.0). Cells were counterstained for 15 s with agitation in non-acidified 1% Eosin Y 
(Fisher Scientific) prior to rinsing cells with 1 mL of an increasing ethanol series (70%, 95%, 
and 100%). Cells were allowed to air dry prior to capture of brightfield images using a Zeiss 
AxioVert-A1 microscope fitted with an Axiocam 503 color camera and using Zen 2.0 Lite 
software 
2.2.7. Determination of senescence-associated beta-galactosidase activity  
Cells were seeded in a 12-well plate, at cell densities of 50,000 cells/well for Xela 
DS2 (passage 9 and passage 74) or Xela VS2 (passage 13 and passage 75), and 30,000 
cells/well for Xela BMW3 as a positive control (passage 11 and passage 20), in 0.5 mL of 
complete medium. Cells were allowed to adhere overnight at 26°C prior to being assessed for 
β-galactosidase activity associated with cellular senescence using a commercially available 
Senescence Cells Histochemical Staining Kit (Sigma Aldrich). The protocol was followed 
according to the manufacturer’s specifications with the following modification: after adding 
the staining mixture to each well, plates were incubated at 26°C instead of 37°C. Briefly, 
complete medium was removed from the adherent cells prior to washing cells twice with 1 
mL of cold APBS. Cells were fixed to the wells of the plate with 0.5 mL fixation buffer for 7 
min. Fixation solution was aspirated and cells washed 3× with 0.5 mL of APBS. The APBS 
was aspirated and 0.5 mL of staining solution was applied to each well prior to incubation at 
26°C overnight. The following day, the cells were washed with APBS prior to taking cell 
images with a phase-contrast microscope (Nikon Eclipse TSX-100 at earlier passage, Zeiss 
AxioVert-A1 at later passage). Digital images were taken of 3-5 fields of view from each 
well for each cell type. The numbers of -galactosidase positive (blue) and negative cells 
(clear) were enumerated from a minimum of 400 cells counted for each cell type. The 
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numbers of cells positive for senescence-associated β-galactosidase activity were expressed 
as a percent of the total number of cells enumerated for each cell type examined. 
2.2.8. Hoechst staining for Mycoplasma detection 
Thirty thousand Xela DS2 (passage 151) and Xela VS2 (passage 135) cells were 
seeded separately onto sterile cover slips (Baxter) in a 6-well plate in 1 mL of complete 
medium. The plate was sealed with parafilm and placed overnight at 26°C. The following 
day, cells adhered to the coverslip were washed with room temperature APBS and fixed 
immediately with an ice-cold acetic acid and methanol fixative at a 1:3 ratio, respectively, for 
20 min at – 20°C. The cells were washed twice with room temperature APBS for 5 min 
under gentle agitation prior to the addition of 1 mL chilled Hoechst 33342 solution (Fisher) 
for 5 min, at a 1:2000 dilution in APBS; protected from light. The cells were washed twice 
with room temperature APBS for 5 min with gentle agitation. Excess liquid was allowed to 
run off the coverslip before being mounted on a glass slide in a 1:10 ratio of 100 mM Tris 
solution (pH 8.0) to glycerol. The slides were kept in the dark at room temperature overnight 
and the coverslips were sealed the following day with nail polish. Images were captured on 
an inverted fluorescent microscope (Zeiss Axio Vert.A1) under oil immersion at 630× 
magnification.  
2.2.9. Determination of optimal growth conditions  
To assess the optimal growth conditions for Xela DS2 and Xela VS2 cell lines, three 
sets of experiments were performed to examine the effect of temperature, percent FBS 
supplementation and seeding density on cell growth. For each experiment, Xela DS2 and 
Xela VS2 cells were harvested from confluent cultures via trypsin treatment. Trypsin was 
inactivated by the addition of complete medium and removed via centrifugation at 500 × g 
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for 5 min. The resultant cell pellet was resuspended in complete medium. Cell concentration 
was determined by mixing a subsample of the cell suspension with Trypan Blue (Invitrogen) 
at a 1:1 ratio and viable cells enumerated using a hemocytometer. Cells were seeded at the 
desired concentration in duplicate or triplicate wells per time point and treatment.  
The first set of experiments aimed to determine the optimal temperature for cell 
growth. Cells were seeded in a 6-well plate in triplicate at cell densities of 40,000 cells/well 
for both Xela DS2 (passages 118-120) and Xela VS2 (between passages 123-129), in 1 mL 
of complete medium. Cells were placed at 26°C overnight to allow cells to adhere. The 
following day, the number of adherent cells was enumerated from the day 0 treatment wells. 
To each of the remaining wells, 1 mL of complete medium was added prior to placing the 
plates at their appropriate experimental temperatures of 14°C, 18°C, 22°C, 26°C, and 30°C. 
The number of viable adherent cells in each well was enumerated after 2 d, 4 d, 6 d, and 8 d 
of growth at differing temperatures. This experiment was repeated three independent times.  
The second set of experiments examined the effect of varying the percentage of FBS 
supplementation on cell growth. Cells were seeded in a 6-well plate in triplicate at cell 
densities of 40,000 cells/well for both Xela DS2 (between passages 118-120) and Xela VS2 
(between passages 123-129), in 1 mL of complete medium. After allowing the cells to adhere 
overnight at 26°C, cells from triplicate wells were enumerated and represent the cell number 
at day 0. To all other wells, the media was removed and replaced with 2 mL of AL-15 
supplemented with either 0%, 2%, 5%, 10%, 15%, or 20% FBS. Plates were placed at 26°C 
for duration of the experiment. After 4 days and 8 days post addition of media supplemented 
with varying percentages of FBS, the number of viable adherent cells in each well were 
enumerated. The experiment was conducted three independent times.  
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In the last set of experiments, the effect of cell density on cellular growth was 
examined. Xela DS2 (between passages 92-102) or Xela VS2 (between passages 93-103) 
cells were seeded in duplicate wells in 1 mL of complete medium at 10,000, 20,000 or 
40,000 cells/well of a 6-well plate. Cells were allowed to adhere overnight at 26°C. The 
following day, cells were harvested for day 0 counts, and to all remaining wells an additional 
1 mL of complete medium was added. Cell growth was monitored by enumerating the 
number of viable adherent cells after 2 d, 4 d, 6 d, and 8 d of incubation at 26°C. The 
experiment was repeated five times (N = 5).  
In all experiments, cells were enumerated by first aspirating media, washing cells 
with 1 mL APBS and then adding 400 μL trypsin to detach cells from the tissue culture 
plates. Once all cells were detached, an equal volume of complete media was added to 
inactivate trypsin and the entire cell suspension was collected in a 1.5 mL microcentrifuge 
tube (Axygen). An additional 400 μL of media was added to the wells to collect any 
remaining cells and added to the corresponding microcentrifuge tube. Samples were 
centrifuged for 5 min at 500 × g and resuspended in a known volume of complete medium. A 
subsample of each cell suspension was mixed 1:1 with trypan blue and counted using a 
hemocytometer. 
2.2.10. DNA isolation 
Total DNA was isolated from 2 × 106 Xela DS2 or Xela VS2 cells using the TRI 
reagent method according to the manufacturer’s instructions. Briefly, cells were collected by 
centrifugation at 500 × g for 5 min and lysed with 1 mL of TRI reagent (Sigma) by pipetting. 
Samples were incubated at room temperature for 5 min prior to the addition of 0.2 mL 
chloroform and vigorous shaking for 15 s. Mixtures were allowed to sit at room temperature 
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for 5 min prior to centrifugation at 12,000 × g for 15 min at 4°C. The top aqueous phase was 
discarded and 0.3 mL of 100% ethanol added to the remaining interphase and organic phase 
and mixed by inversion. Samples were left at room temperature for 3 min before 
centrifugation at 2,000 × g for 5 min at 4°C. The supernatant was removed and the DNA 
pellet was washed 2 × with 1 mL of 0.1 M sodium citrate in 10% ethanol. Between washes, 
the DNA pellet was allowed to stand in the sodium citrate/ethanol wash solution for 30 min, 
vortexed and centrifuged at 2,000 × g for 5 min at 4°C. The supernatant was removed and the 
DNA pellet was further washed 2 × with 1.5 mL 75% ethanol. Between washes, the DNA 
pellet was allowed to stand in the ethanol wash solution for 20 min, vortexed and centrifuged 
at 2,000 × g for 5 min at 4°C. The ethanol was aspirated and the DNA pellet allowed to air 
dry for approximately 10 minutes before being resuspended in TE (Tris-EDTA) buffer (pH 
8.0). Total DNA quantity and purity was determined using a NanoDrop 1000 
Spectrophotometer. 
2.2.11. DNA barcoding 
PCR reaction conditions and barcoding primers for amphibians were adapted from 
Che et al, 2012. Taxonomic DNA barcoding sequences the 5’-region of cytochrome c 
oxidase subunit I mitochondrial gene; for amphibians, the forward degenerate primer 
sequence was 5’-TYTCWACWAAYCAYAAAGAYATCGG-3’ and reverse degenerate 
primer sequence was 5’-ACYTCRGGRTGRCCRAARAATCA-3’ (Che et al., 2012). PCR 
reactions consisted of (final concentrations) PCR reaction buffer containing 2mM MgCl2 
(GeneDireX), 200 nM dNTP (GeneDireX), 200 nM sense and antisense primers (Sigma), 
0.625 U Taq DNA Polymerase (GeneDireX), and 50 ng DNA template in a 25 μL reaction 
volume. The cycling conditions were as follows: initial denaturation at 95°C for 10 min; 35 
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amplification cycles of 94°C for 1 min, annealing at 45°C for 1 min and elongation at 72°C 
for 1 min; followed by a final extension step at 72°C for 10 min. In tandem with the PCR, a 
no template control using molecular grade water was used. To each PCR reaction, 5 µL of 6× 
loading buffer [0.15% xylene cyanol (ICN Biomedicals), 30% v/v glycerol (EMD 
Chemicals)] was added prior to loading into a 2.0% agarose (VWR) gel containing 1× 
RedSafe Nucleic Acid Staining Solution (FroggaBio) and electrophoresed in 1× Tris-
Acetate-EDTA (TAE) buffer at 140 V for 20 min.  
To purify DNA amplicons from agarose gel slices, bands were excised from the gel, 
placed in a 1.5 mL microcentrifuge tube and frozen at -80°C for 30 min. A hole was 
punctured in the bottom of a 0.5 mL tube (LifeGene), stuffed with a small amount of glass 
wool (Acros Organics), and the frozen gel slice added. The 0.5 mL tube containing the gel 
slice was placed inside a 1.5 mL microcentrifuge tube and centrifuged at 14,500 × g for 5 
min. To the flow through, 0.1 volumes of 3 M sodium acetate and 1 volume of isopropanol 
was added. Samples were vortexed before centrifugation at 14,500 × g for 15 min. The pellet 
was washed 2 × with 1 mL of 70% ethanol, vortexed and centrifuged at 14,500 × g for 5 min 
at 4°C between washes. The precipitated DNA amplicons were resuspended in molecular 
grade water, cloned into the pUCM-T cloning vector (BioBasic) according to manufacturer’s 
instructions, and transformed into chemically competent Escherichia coli XL1-Blue by heat 
shock (1 min, 42°C). Transformed cells were allowed to recover for 1 h at 37°C with shaking 
at 220 rpm in SOB medium (2% w/v tryptone, 0.5% w/v yeast extract, 8.56 mM NaCl, 2.5 
mM KCl, 10 mM MgCl2). Transformed bacteria were plated on LB agar plates containing 
100 µg/mL ampicillin (Fisher), 2 mg X-gal (BioBasic) and 2 µmol IPTG (Fisher) at 37°C 
overnight. The following day, white colonies were selected and the presence of inserts 
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confirmed by colony PCR using M13 forward (5’-TTGTAAAACCGACGGCCAGTG -3’) 
and reverse (5’-GGAAACAGCTATGACCATGATTACGC -3’) primers. Positive colonies 
were inoculated in 2 mL of LB broth containing 100 µg/mL ampicillin and grown overnight 
at 37°C with shaking at 220 rpm. The next day, bacteria were collected by centrifugation 
(10,000 × g, 5 min) and plasmids isolated using a modified plasmid isolation protocol. 
Briefly, bacterial pellets were resuspended in 100 µL of ice-cold 50 mM glucose, 10 mM 
EDTA, 25 mM Tris, pH 8.0 and vortexed to mix. To this mixture, 200 µL of room 
temperature 0.2 N NaOH, 1.0% SDS solution was added to the suspension and inverted to 
mix, followed by the addition of 150 µL of ice-cold 3 M KOac, pH 6.0. Lysates were 
centrifuged at 15,500 × g for 30 min at 4°C. The supernatant was transferred to a new 1.5 mL 
microcentrifuge tube and incubated with 20 µg RNase A (BioBasic) for 20 min at 37°C. 
After incubation, 2.5 volumes of isopropanol was added, the solution inverted to mix, and 
centrifuged at 15,500 × g for 30 min at 4°C. The plasmid pellet was washed 2 × with 1 mL of 
70% ethanol by vortexing and centrifuging at 15,500 × g for 5 min at 4°C between washes. 
Ethanol was aspirated and the plasmid DNA pellet allowed to air dry before being 
resuspended in molecular grade water. A minimum of 10 positive clones generated from 
each cell line were sent to the TCAG Facility at The Centre for Applied Genomics (Toronto, 
Ontario, Canada) for sequencing. Resulting sequences were subjected to Clustal Omega 
multiple sequence alignment (MSA) against the complete genome of X. laevis mitochondrion 
(GenBank Accession HM991335.1) to confirm the identity of the amplicons (Appendix A for 
Xela DS2 MSA, Appendix B for Xela VS2 MSA).  
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2.2.12. Total RNA isolation and cDNA synthesis  
Total RNA was isolated from 1×106 Xela DS2 or Xela VS2 cells using the EZ-10 
Spin Column Total RNA Minipreps Super Kit (Bio Basic Canada Inc.) according to 
manufacturer’s instructions, with the following modification in order to include an on-
column DNaseI digestion: Following the first RW wash step, 30 µL of DNase I solution 
containing 5 U of DNase I (Thermo Scientific) was added to the spin column for 20 min at 
room temperature. Afterwards, 500 μL of RW solution was added to the column and left at 
room temperature for 2-3 min before spin column centrifugation at 6,000 × g for 1 min.  
Isolation of total RNA from X. laevis skin tissues, previously stored at −80°C, was 
performed using TRI reagent according to the manufacturer’s instructions. Briefly, X. laevis 
dorsal and ventral skin were ground to a powder using a mortar and pestle under liquid 
nitrogen and transferred to a 1.5 mL microtube containing 1 mL of TRI reagent. Tissues were 
homogenized by passage through a 1 mL syringe fitted with a 25½ gauge needle. Once 
homogenized, samples were placed on ice for 5 min prior to centrifugation at 12,000 × g for 
10 min at 4°C to remove particulates. The supernatant was transferred to a new tube to which 
0.2 mL chloroform was added and samples shaken vigorously for 15 s. Mixtures were 
allowed to sit at room temperature for 5 min prior to centrifugation at 12,000 × g for 15 min 
at 4°C. The top aqueous phase was transferred to a new tube containing 0.5 mL isopropanol 
and mixed by inversion. Samples were left on ice for 10 min followed by centrifugation at 
12,000 × g for 10 min at 4°C. The supernatant was removed and the RNA pellet was washed 
2× with 1 mL of 75% ethanol, vortexed and centrifuged at 12,000 × g for 5 min at 4°C 
between washes. Ethanol was aspirated and the RNA pellet allowed to air dry before being 
resuspended in molecular grade water. RNA was treated with DNAseI (Fermentas) according 
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to the manufacturer specifications. Total RNA quantity and purity was determined using a 
NanoDrop 1000 Spectrophotometer. RNA quality was further assessed by running 1 μg RNA 
on a 2.0% agarose gel containing 1× RedSafe Nucleic Acid Staining Solution and 
electrophoresed in 1× TAE buffer at 120 V for 30 min. 
RNA was reverse transcribed into cDNA using the SensiFAST cDNA Synthesis Kit 
(BioLine) according to manufacturer’s specifications. Briefly, 500 ng of RNA was mixed 
with 4 µL of 5× reaction mix in a total volume of 20 µL. The resulting reactions were 
incubated at 25°C for 10 min, 42°C for 15 min and the reaction inactivated by incubation at 
85°C for 5 min. Synthesized cDNA was stored at -20°C until use. 
2.2.13. Reverse transcriptase polymerase chain reaction (RT-PCR) for the 
detection of cell type transcript markers  
Primers for X. laevis -actin (actb), collagen type I A1 (col1a1), collagen type I A2 
(col1a2), collagen type III (col3), cytokeratin 5 (krt5), cytokeratin 14 (krt14), cytokeratin 19 
(krt19), vimentin (vim), cadherin 1 (cdh1), claudin 1 (cldn1), claudin 3 (cldn3), and occludin 
(ocln) (Table 2.1) were designed using the online PrimerQuest tool from Integrated DNA 
Technologies (IDT; https://www.idtdna.com/Primerquest/Home/Index). RT-PCR reactions 
(25 µL reactions) consisted of (final concentrations) PCR reaction buffer containing 2 mM 
MgCl2, 200 μM dNTP, 200 nM sense and antisense primers (Sigma), 0.625 U Taq DNA 
polymerase. Reaction template included cDNA generated from isolated X. laevis dorsal skin 
and ventral skin tissue RNA, and cDNA generated from Xela DS2 (between passages 72-88) 
and Xela VS2 (between passages 73-89) RNA samples. For cell type marker detection 
(col1a1, col1a2, col3, krt5, krt14, krt19, vim, actb) the cycling conditions were as follows: 
initial denaturation at 95°C for 5 min; 35 amplification cycles (krt5), 32 amplification cycles 
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(col1a1, col1a2, col3, krt14, krt19), or 26 amplification cycles (vim, actb) of 95°C for 45 s, 
annealing at 55°C for 30 s and elongation at 72°C for 45 s; followed by a final extension step 
at 72°C for 5 min. For gap junction marker detection (cdh1, cldn1, cldn3, ocln, actb) the 
cycling conditions were as follows: initial denaturation at 95°C for 5 min; 28 amplification 
cycles (cdh1, cldn1, cldn3, ocln), 23 amplification cycles (actb) of 95°C for 45 s, annealing 
at 57°C for 30 s and elongation at 72°C for 45 s; followed by a final extension step at 72°C 
for 5 min. A no template control was set up for all primer sets, and an RNA only control for 
each RNA sample was set up using β-actin primers. Both sets of RT-PCR reactions were 
repeated three times, using cDNA generated from Xela DS2 and Xela VS2 RNA at three 
different passages. To each RT-PCR reaction, 5 µL of 6× loading buffer (0.15% xylene 
cyanol, 30% v/v) was added prior to loading into a 2.0% agarose gel containing 1× RedSafe 
Nucleic Acid Staining Solution and electrophoresed in 1× TAE buffer at 140 V for 20 min. 
Gels were imaged via ChemiDoc imager using Image Lab program. Bands were excised 
from the gel, purified, and prepared for sequencing as described in Section 2.2.11. Resulting 
sequences were subjected to BLASTn (Altschul et al., 1990) analysis to confirm the identity 
of the amplicons (Appendix C). 
2.2.14.  Treatment of Xela DS2 and Xela VS2 cells with poly(I:C)  
Xela DS2 (between passages 110-116) or Xela VS2 (between passages 111-118) cells 
were seeded in a 6-well plate at a cell density of 2 × 106 cells per well in 1 mL of complete 
medium and allowed to adhere overnight at 26°C. At the time of treatment, medium was 
replaced with 2 mL of fresh complete medium (time-matched controls) or complete medium 
containing 10 μg/mL polyinosinic-polycytidylic acid [poly(I:C), Sigma Aldrich Catalogue #  
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Table 2.1. List of primers used for RT-PCR in the identification of Xela DS2 
and Xela VS2 cell type.  
 
Gene target  Sequence (5’→3’) Accession Number  
actb 
S – ATCGTGGGGCGCCCCAGGCACC| 
AS - CTCCTTAATGTCACGCACGATTTC 
NM_001091337.1 
Fibroblast cell markers 
col1a1 
S – ATTCAACGGACCCTCTGGAC 
AS – ATCTTCAGGTCACGGCAGGT 
NM_001087352.1 
col1a2 
S – AGCGTGGCTATCCTGGAAAC 
AS - ATTCACCACCAAAGCCACCA 
NM_001087258.1 
col3 
S – CTGGTGGTCGTGGTATTGTT 
AS - TTAGATCCTGGTGGTCCTCTT 
NM_001090075.1 
Epithelial cell markers 
krt5 
S – GTCATCAGCTCTGGAGGCAA 
AS - TGCACAGACAATGCTTGAGAG 
NM_001085584.1 
krt14 
S – TTTTGACCGGTGGCACTTCT 
AS - CAACTCCCACACTGGACCTG 
NM_001166441.1 
krt19 
S – CCAAGTCGGTGGACAAATTA 
AS - CCATAACGGGCTTCTGTTT 
NM_001091523.1 
Mesenchymal cell marker 
vim 
S - CTGTCGGAAGCTGCTAATC  
AS - CAACCTGTCCATCTCTTGTC 
NM_001087439.1 
Epithelial adherens junction marker 
cdh1 
S - ACAGTGAAGGGTTTGGACTATG  
AS - CACCAGTCAGCTCTGCTTTAT 
NM_001172232.1 
Epithelial tight junction marker 
cldn1 
S - CTGGGCTGGATTGGGTTTATAG   
AS - CTACTCCAACCTTTGCCTTCTT   
NM_001085976.1 
cldn3 
S - GGATGGATAGGAAGTGTGGTATG   
AS - GTTGACCTGGCAGCTGTATAA   
NM_001093931.1 
ocln 
S - CTTCTGGATCGGCTTTCTACAC   




P1530-25MG]. Phase contrast digital images were taken of control and poly(I:C) treated cells 
at 0 h, 3 h, 6 h, 12 h, and 24 h post treatment using a Leica DMi1 microscope fitted with a 
MC170 color camera and LASX 4.8 software to assess cell morphology. At each time point, 
cells from time-matched controls and poly(I:C) treatments were harvested by using a cell 
scraper to lift adherent cells from the culture vessel surface into suspension. This was 
collected and centrifuged at 230 × g for 10 min, collecting both previously adherent cells as 
well as cells which lost adherence from poly(I:C) treatment. The supernatant was aspirated 
and the cell pellet was used for total RNA isolation using the EZ-10 Spin Column Total RNA 
Minipreps Super Kit as described in Section 2.2.12. Assessments of RNA quantity, purity, 
and integrity, and subsequent cDNA synthesis, were performed as described in Section 
2.2.12. The cDNA samples were stored at -20°C until use in quantitative RT-PCR (qRT-PCR) 
transcript analysis. 
2.2.15. RT- qPCR of Xela DS2 and Xela VS2 poly(I:C) stimulated cells 
Primer sequences and accession numbers for X. laevis tumor necrosis factor (tnf), 
interleukin-1 (il1), interleukin-8 (il8), inhibitor of kappa B (ikb), type I interferon (ifn1), 
protein kinase R (pkr), and myxovirus resistance gene 2 (mx2) can be found in Table 2.2; 
primer efficiencies and R2 values are also reported. Prior to transcript analysis, gene stability 
testing was conducted for actb, cyclophilin (cyp), elongation factor 1-α (ef1a), 
glyceraldehyde 3-phosphate dehydrogenase (gapdh), and hypoxanthine-guanine 
phosphoribosyltransferase (hgprt) to determine a stable endogenous control selection. cDNA 
samples across all trials generated from Section 2.2.12 was pooled together in a time-
matched and treatment-matched fashion, then diluted to 1:40 for all reactions. RT-qPCR 
reactions were prepared in triplicate and consisted of (final concentrations) 250 nM sense and 
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antisense primer, 5 µL PowerUp SYBR green mix (Thermo Scientific), and 2.5 µL of 1:40 
diluted, pooled cDNA at a final reaction volume of 10 µL. All reactions were prepared in a 
MicroAmp fast optical 96-well reaction plate and optical film (Life Technologies) and run on 
QuantStudio5 Real-Time PCR System (Thermo Scientific). The cycling conditions were as 
follows: initial denaturation at 50°C for 2 min, followed by 95°C for 2 min, 40 amplification 
cycles of denaturation at 95°C for 1 s, and extension at 60°C for 30 s. A melt curve step 
followed all runs to ensure only a single dissociation peak was present, with initial 
denaturation at 95°C for 1 s, then dissociation analysis at 60°C for 20 s followed by 0.1°C 
increments between 60°C and 95°C at 0.1°C/s. Gene stability measures (M-value) were 
determined for all endogenous control candidates, wherein a lower M-value infers stronger 
gene stability across time and treatment. The lowest M-value was for ef1a at 0.278 and 0.217 
for Xela DS2 and Xela VS2, respectively; ef1a was thus selected as the endogenous control 
(Table 2.3). For transcript analysis, cDNA generated from Section 2.2.12 was diluted to 1:20 
for all reactions. RT-qPCR reactions were prepared in triplicated and consisted of 500 nM 
sense and antisense primer, 5 µL PowerUp SYBR green mix, and 2.5 µL of 1:20 diluted 
cDNA in a final reaction volume of 10 µL. The cycling conditions and melt curve step were 
performed as previously described. All reactions were prepared in a MicroAmp fast optical 
96-well reaction plate and optical film and run on QuantStudio5 Real-Time PCR System. 
RT-qPCR reactions for transcript analysis were repeated five times, using cDNA generated 
from experiments outlined in Section 2.2.14 (N = 5). Amplicons from all primer sets used in 
RT-qPCR reactions were sequenced as described in Section 2.2.11 and resulting sequences 
were subjected to BLASTn (Altschul et al., 1990) analysis to confirm the identity of the 
amplicons and amplification of a single gene target (Appendix D). 
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R2 Accession Number 
actb 
S - GAGCTGCCTGACGGACAAGT 
AS - TACCGCAGGATTCCATACCAA  
102.919 0.998 NM_001088953.2 
cyp 
S - TGTGCCAGGGAGGTGACTTC 
AS - CCAGTGTGCTTCAGGGTGAA 
104.165 0.998 NM_001089190.1 
ef1a 
S - GTTCATTTACCGCACAGGTTATC    
AS - CGGCGATCAATCTTCTCCTT 
97.232 0.998 NM_001087442.1  
gapdh 
S - GGGAATCCTGGGATACACACA 
AS - ATTCAGGGCAATTCCAGCAT 
105.677 0.998 NM_001087098.1 
hpgrt 
S - AAGACTTTGCTTGCTATGCTCAAG 
AS - CTGGCCTGTATCCCACACTTC 
103.420 0.998 NM_1096766.1 
Antiviral targets 
ifn1 
S - GCTGCTCCTGCTCAGTCTCA  





S - GGAACGCCGCACTTGCAGAA    





S - GCTCACCGGCGGGATTA   






S - TATCCGCCGTTCATACAAGGA   
AS - GATTTCGTGTTGCTCGGT 
86.674 0.999 NM_001093529.1 
il1 
S - CATTCCCATGGAGGGCTACA   





S - CCTATCCATCCCAAGCACATAAA    
AS - GATATCGTCCCCACTTGTCAAAG 
92.658 0.998 NM_001097106.1  
tnf 
S - TGTCAGGCAGGAAAGAAGCA    








For cell growth experiments, data were analyzed by a two-way analysis of variance 
(ANOVA) for the relationship between treatment and time with a Tukey’s post hoc analysis. 
Groups were considered statistically significant groups when p < 0.05. For RT-qPCR 
analysis of Xela DS2 and Xela VS2 poly(I:C) stimulated cells, statistical analysis was 
performed by using a Mann-Whitney test with Bonferroni correction, which considers each 
time-point (4 total) as an independent test, correcting initial p < 0.05 to p < 0.0125. As such, 
statistical significance (*) was determined within each time-point between treated cells and 
their time matched control wherein significant groups have p < 0.0125. Statistical analyses 
were performed using GraphPad Prism v6 software. 
Table 2.3. Candidate endogenous genes for use in RT-qPCR analysis of poly(I:C) 
treated Xela DS2 and Xela VS2 cells. 
Target 
Xela DS2  
M-Value 
Xela VS2  
M-Value 
actb 0.528 0.266 
cyp 0.354 0.226 
ef1a 0.278 0.217 
gapdh 0.290 0.348 
hgprt 0.367 0.298 
 
2.3. Results 
2.3.1. Development of Xela DS2 and Xela VS2 cell lines and cell characteristics 
In order to elucidate the contribution of skin epithelial cells to amphibian innate immune 
responses, I established skin epithelial-like cell lines from the dorsal and ventral skin of X. 
laevis. Within one week of placing X. laevis dorsal skin or ventral skin tissue explants in 
tissue culture flasks, cells were seen migrating out of the tissues (not shown). These cells 
appeared to have an epithelial-like morphology with simple epithelium structure as seen by a 
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single layer of polygonal cells with close cell-to-cell contact. Over a period of 3 – 4 months, 
a flask containing dorsal skin fragments and a flask containing ventral skin fragments, 
originating from the same animal, produced large islands of adherent single-layered cells 
surrounding the central mass of tissue and covered ~60-70% of the area in the flask. Trypsin 
treatment was used to readily detach the cells over subsequent passages, leading to 
continuous propagation. The resulting cell lines originating from X. laevis dorsal skin and 
ventral skin tissue explants were named Xela DS2 and Xela VS2, respectively. During this 
time, Xela DS2 and Xela VS2 consistently displayed epithelial-like morphology. At early 
cell passages of passage 9 for Xela DS2 (Fig. 2.1A) and passage 13 for Xela VS2 (Fig. 2.1E), 
cells were largely adherent and epithelial-like in morphology (Fig. 2.1A, E). While earlier 
passages of Xela DS2 and Xela VS2 had slow and patchy growth, later passages of Xela DS2 
(Fig. 2.1B) and Xela VS2 (Fig. 2.1F) grew more rapidly and formed confluent monolayers. If 
cell cultures became over-confluent, cells would begin to lose adherence. Both Xela DS2 and 
Xela VS2 cell lines are now routinely maintained in complete medium without antibiotics 
and were split 1:4 every 3-4 days. Xela DS2 and Xela VS2 have been passed >160 times 
over 4 years since their initial establishment and have been successfully cryopreserved at a 
variety of passages in complete medium containing 10% DMSO. Xela DS2 and Xela VS2 
cell lines were confirmed to be of X. laevis origin by sequencing a region of the cytochrome 
c oxidase I (COI) gene followed by NCBI BLASTn analysis that returned an identical hit for 
X. laevis cytochrome c oxidase subunit I in the mitochondrial genome (GenBank Accession 
HM991335.1). Clustal Omega multiple sequence alignment (MSA) via EMBL-EBI (Madeira 
et al., 2019) of the 10 isolated colonies containing Xela DS2 and Xela VS2 COI against X. 





Figure 2.1. Xela DS2 and Xela VS2 cells exhibit epithelial cell-like morphology. Phase-contrast digital images of Xela DS2 
cells were taken at passage 9 (A), passage 39 (B), and passage 72 (C), and of Xela VS2 cells at passage 13 (E), passage 42 (F), and 
passage 73 (G). Bright-field digital images of Hematoxylin and Eosin stained Xela DS2 cells (D) and Xela VS2 cells (H). Scale 




Figure 2.2. Senescence associated -galactosidase activity of Xela DS2 and Xela VS2 
cells from early and established cultures. Xela DS2 and Xela VS2 cells were tested for 
senescence associated -galactosidase activity and visualized under phase-contrast 
microscopy. Cells positive for -galactosidase activity appear blue. Digital images of 
Xela BMW3 cells at passage 11 (A), Xela DS2 cells at passage 9 (C), Xela VS2 cells at 
passage 13 (E), Xela BMW3 cells at passage 20 (B), Xela DS2 cells at passage 74 (D) and 
Xela VS2 cells at passage 75 (F). Xela BMW3 cells were used as a positive control for -
galactosidase activity. The percent -galactosidase positive cells is indicated in the top-
right hand corner of each image. Scale bars represent a distance of 50 μM. 
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To characterize cell morphology, cells were stained with Hematoxylin-Eosin. Xela 
DS2 cells were characterized by oval nuclei and light pink cytoplasm (Fig. 2.1D), while Xela 
VS2 cells also had oval nuclei but relatively clear to light purple cytoplasm (Fig. 2.1H) and 
both cell lines appeared epithelial-like with polygonal morphology. At lower cell densities, 
some Xela DS2 and Xela VS2 cells also appeared crescent-like (Fig. 2.1D, H). Furthermore, 
at higher cell densities, Xela DS2 and Xela VS2 become compact and had an average cell 
diameter of approximately 35 μm. Cells from Xela BMW3 continuous cell cultures derived 
from X. laevis bone marrow were used as a positive control for cellular senescence as these  
cells previously stained positive for β-galactosidase activity (unpublished data). At passage 
11 (Fig. 2.2A) and passage 20 (Fig. 2.2B), 16% and 46% of the BMW3 cells appeared blue, 
respectively, indicative of β-galactosidase activity. At early passages, Xela DS2 (passage 9) 
and Xela VS2 (passage 13) exhibited 3% and 24% cellular senescence, respectively (Fig. 
2.2C, E). However, with successive passages both Xela DS2 (Fig. 2.2D) and Xela VS2 (Fig. 
2.2F) cells lost -galactosidase activity.  In addition, Xela DS2 and Xela VS2 were tested for 
potential mycoplasma contamination by employing the Hoechst staining method. 
Extranuclear fluorescent foci were not observed in Xela DS2 or Xela VS2 cultures (Fig. 2.3). 
2.3.2. Effect of culture conditions on Xela DS2 and Xela VS2 cell growth 
Although other X. laevis cell lines are routinely cultivated in osmotically adjusted 
medium containing FBS, the percentage of FBS and incubation temperature varies with the 
cell line (Pudney et al., 1973; Rafferty, 1969; Sakaguchi et al., 1989). Therefore, I undertook 
studies to determine the optimal level of serum supplementation and incubation temperature 
for Xela DS2 and Xela VS2. In general, Xela DS2 and Xela VS2 cell growth occurred in an 







significant effect due to time (p < 0.0001) and FBS treatment (p < 0.0001) for both Xela DS2 
and Xela VS2. In the absence of FBS supplementation, or with only 2% FBS, no significant 
differences in cell numbers were observed in Xela DS2 (Fig. 2.4A) or Xela VS2 (Fig. 2.4B) 
cultures over 8 days at 26°C. However, I noted that Xela DS2 and Xela VS2 cells started to 
lose adherence to the tissue culture vessel over time when cultured in the absence of FBS; 
whether this was due to cell death was not assessed. Supplementation of cultures with 5% 
FBS also did not support statistically significant proliferation of Xela DS2 (Fig. 2.4A) or 
Xela VS2 cells (Fig. 2.4B), although there were roughly 4-fold as many cells by day 8 of 
culture for both cell lines. A minimum of 10% FBS was required to promote significant 
increases in cell numbers in Xela DS2 (Fig. 2.4A) or Xela VS2 (Fig. 2.4B) over 8 days. 
Indeed, fold change in Xela DS2 (Fig. 2.4A) and Xela VS2 (Fig. 2.4B) cell numbers 
increased in a dose-dependent manner with FBS supplementation after 8 days, achieving a  
Figure 2.3. Hoechst staining of Xela DS2 and Xela VS2 cells. (A) Xela DS2 at passage 
151 (B) Xela VS2 at passage 135. Both cell lines exhibit nuclei with no evidence of 






Figure 2.4. Fold change in cell growth for Xela DS2 and Xela VS2 cells under 
varying conditions. Fold change in Xela DS2 (A) and Xela VS2 (B) cell numbers when 
seeded at 40,000 cells per well and grown at 26°C in AL-15 medium supplemented with 
0%, 2%, 5%, 10%, 15%, 20%, or 30% FBS (n = 3 independent trials). Fold change in 
Xela DS2 (C) and Xela VS2 (D) cell numbers when seeded at 40,000 cells per well and 
grown in AL-15 supplemented with 15% FBS at varying temperatures (n = 3 independent 
trials). Fold change Xela DS2 (E) or Xela VS2 (F) cell numbers after being seeded at 
varying initial cell densities and grown at 26˚C in AL-15 medium supplemented with 15% 
FBS (n = 5 independent trials). For all experiments, viable cells were enumerated on the 
indicated day and expressed as a fold change in cell number relative to the corresponding 
Day 0 time point. Significant differences were determined by a two-way ANOVA and a 





maximum ~10-fold increase in cell numbers when cultured in the presence of a minimum of 
15% FBS for Xela DS2 (Fig. 2.4A) or 10% FBS for Xela VS2 (Fig. 2.4B). Based on these 
results, 15% FBS supplementation was chosen for maintenance of, and further 
experimentation with, Xela DS2 and Xela VS2.  
Both Xela DS2 and Xela VS2 showed a time and temperature-dependent increase in 
cell number. Two-way ANOVA analysis indicated that there was a significant effect due to 
time (p < 0.0001) and incubation temperature (p = 0.01850 for Xela DS2, p < 0.0001 for 
Xela VS2) in both Xela DS2 and Xela VS2. Growth of Xela DS2 (Fig. 2.4C) and Xela VS2  
(Fig. 2.4D) cells were minimally supported at lower temperatures of 14°C and 18°C after 8 
days of cultivation. However, both Xela DS2 (Fig. 2.4C) and Xela VS2 (Fig. 2.4D) 
demonstrated significant growth over eight days at temperatures above 22°C, with no 
significant difference in fold change in cell number at 8 days post seeding across the 22°C, 
26°C and 30°C for Xela DS2 (Fig. 2.4C) or 22°C and 26°C for Xela VS2 (Fig. 2.4D). Over 8 
days of cultivation, Xela DS2 cells exhibited a 9-fold, 9-fold and 8-fold change in cell 
number when grown at 22°C, 26°C and 30°C (Fig. 2.4C), respectively, while Xela VS2 
exhibited an 8-fold, 10.5-fold, and 7.5-fold change in cell number at identical growth 
temperatures (Fig. 2.4D). While no distinct changes in cellular morphology were noted for 
Xela DS2 or Xela VS2 at 14°C, 18°C, or 26°C, cells appeared unable to reach well 
confluency at 30°C as cells began to lose adherence between 6 and 8 days of cultivation (not 
shown; personal observation). Since Xela DS2 and Xela VS2 appeared to have optimal cell 
growth over 8 days of cultivation at 26°C, this temperature was selected to maintain the cells 
and to conduct further studies.  
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To assess if Xela DS2 or Xela VS2 cells demonstrated contact inhibition, since cells 
grow in a monolayer and thus have limited space for growth, cells were seeded at 10,000 
cells/well, 20,000 cells/well, or 40,000 cells/well in complete medium and cultured for 8 
days at 26°C. Two-way ANOVA analysis indicated that there was a significant effect of time 
(p < 0.0001) but not seeding cell density (p = 0.5607 for Xela DS2, p = 0.6700 for Xela VS2) 
on the growth of Xela DS2 and Xela VS2. At an initial seeding cell density of 10,000, 20,000, 
or 40,000 cells per well, Xela DS2 cells (Fig. 2.4E) exhibited a 26-fold, 18-fold, and 12-fold 
change in cell number over 8 days of cultivation, respectively, albeit not statistically 
significant from each other. Consistent growth of Xela DS2 was observed at all initial 
seeding cell densities up to day 4, wherein there was a reduction in the expected levels of 
fold change in cell numbers in the wells seeded at 20,000 or 40,000 cells per well. Visually, 
Xela DS2 cells appeared to reach well confluency by day 8 for cells initially seeded at 20,000 
cells per well, while confluency appeared to be reached by day 6 for cells initially seeded at 
40,000 cells per well. In contrast, Xela VS2 (Fig. 2.4F) exhibited a 7.5-fold, 11-fold, and 8-
fold change in cell number after 8 day of culture after initially being seeded at 10,000 
cells/well, 20,000 cells/well, or 40,000 cells/well, respectively. Unlike Xela DS2, Xela VS2 
cells did not appear to reach confluency by day 8 of cultivation across all seeding cell 
densities when comparing monolayer morphologies through phase contrast.  
2.3.3. Xela DS2 and Xela VS2 express molecular markers of epithelial cells 
To characterize the cell type present in Xela DS2 and Xela VS2, the molecular 
signatures of Xela DS2 and Xela VS2 were investigated and gene targets selected based on 
those typically expressed in mammalian fibroblast cells, epithelial cells and mesenchymal 
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Figure 2.5. Xela DS2 and Xela VS2 have unique molecular signatures characteristic 
of epithelial cells. Gel electrophoresis from RT-PCR for cell type markers of dorsal skin 
tissue (DS Tissue), Xela DS2, ventral skin tissue (VS Tissue), and Xela VS2. Gene targets 
include fibroblastic molecular markers col1a1, col1a2, col3, epithelial molecular markers 
krt5, krt14, krt19, mesenchymal marker vim, and actb as an endogenous control. Gel 
electrophoresis from RT-PCR for epithelial gap junction markers was performed on the 
same set of samples. Gene targets include adherens junction marker cdh1, tight junction 
markers cldn1, cldn3, ocln, and actb as an endogenous control. NTC, no template control 




which are necessary for extracellular matrix formation (Miskulin et al., 1986; Vuorio et al., 
1987). Epithelial cells express an array of cytokeratin for structural support such as krt5 and 
krt14 in epidermal stratified squamous epithelium, or krt19 in simple epithelium (Chu and 
Weiss, 2002; Moll et al., 1982). Finally, vim was selected as a marker of mesenchymal cells 
since epithelial cells are known to undergo an epithelial to mesenchymal transition (EMT) in 
instances (Chaw et al., 2012; Mendez et al., 2010). Dorsal and ventral skin tissues from X. 
laevis expressed all the gene targets examined (Fig. 2.5), with the exception of krt14 that did 
not appear to be expressed in dorsal skin tissue. Xela DS2 demonstrated robust expressions 
of col1a2, krt19, and vim, and barely detectable expressions of col1a1 and col3 (Fig. 2.5). 
Expressions of krt5 and krt14 in Xela DS2 were not detected (Fig. 2.5). Xela VS2 expressed 
col1a1, col1a2, col3, krt5, krt19, and vim genes (Fig. 2.5). However, Xela VS2 did not 
appear to express krt14 (Fig. 2.5).  
To further ascertain the cell type identities of Xela DS2 and Xela VS2, the 
expressions of genes involved in encoding for tight and adherens junction proteins, essential 
to the integrity of the epithelial barrier (Menco, 1980; Villaro et al., 1998), were examined. 
Tight junctions are strictly localized to epithelial and endothelial cells, requiring claudin and 
occludin family membrane proteins for formation, while adherens junctions require cadherin 
family proteins to be functional (Coyne et al., 2003; Yap et al., 1997). Both Xela DS2 and 
Xela VS2 expressed cdh1, cldn1 and ocln genes (Fig. 2.5), wherein cdh1 is strictly localized 
to epithelial cells in mammalian systems. The expression of cldn3 is detected at relatively 
low levels in frog skin tissue but remains undetected in Xela DS2 or Xela VS2 (Fig. 2.5).  
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  Figure 2.6. Xela DS2 and Xela VS2 cells lose adherence following treatment with poly(I:C). Phase contrast images showing 
cell morphology of Xela DS2 and Xela VS2 cells in the absence or presence of 10 µg/mL of poly(I:C). Non-treated Xela DS2 or 
Xela VS2 cells form adherent monolayers with very few non-adherent cells observed. Treatment of Xela DS2 and Xela VS2 cells 
with poly(I:C) results in cellular loss of adherence as early as 3 h post treatment. Images were taken at 100× magnificent, and scale 




2.3.4. Effect of poly(I:C) treatment on Xela DS2 and Xela VS2 cell adherence 
To assess the potential effects of dsRNA on Xela DS2 and Xela VS2 cell adherence, 
Xela DS2 and Xela VS2 were treated with 10 µg/mL poly(I:C) at 26°C. Upon treatment of 
Xela DS2 and Xela VS2 with poly(I:C), a proportion of cells exhibited a loss of adherence to 
the tissue culture vessel, appearing as suspension cells in the media within 3 h post treatment 
(Fig. 2.6). Following this initial loss of cell adherence, no further loss of cell attachment was 
observed over the 24 h treatment period (Fig. 2.6). Sampling of the suspension cells at the 24 
h time point revealed the exclusion of trypan blue by these suspension cells, suggesting their 
membranes were intact and the cells still viable at this time point. Non-treated Xela DS2 and 
Xela VS2 cells did not exhibit any changes in cell morphology or adherence to the tissue 
culture vessel over the 24 h time period (Fig. 2.6). 
2.3.5. Effect of poly(I:C) treatment on antiviral gene expressions in Xela DS2 
and Xela VS2  
I next assessed whether poly(I:C) might also be a potent inducer of type I interferon 
(ifn1) in Xela DS2 and Xela VS2. First, it is important to note that X. laevis ifn1 primers were 
accessed, and this study conducted, prior to the identification of the expanded X. laevis 
intron-containing and intronless IFNs {Sang, 2016 #419}. As such, while the primer set used 
for this study has been annotated for identification of type I IFN, the actual amplified target 
may be within the expanded X. laevis Type I IFN family. Xela DS2 showed an initial 3.9 ± 
0.7 fold (p = 0.0079) increase in ifn1 transcripts at 3 h post treatment and transcript levels 
continued to increase in a time-dependent manner, reaching a 7.7 ± 2.6 fold (p = 0.0079) 
increase at 12 h post treatment relative to the time-matched controls (Fig. 2.7A). Although 
ifn1 transcript levels were 20.0 ± 9.7 fold (p = 0.0317) higher than the time matched non-


















Figure 2.7. Poly(I:C) treatment induces upregulation of type I interferon and 
interferon stimulated genes in Xela DS2 and Xela VS2. RT-qPCR was performed on 
cDNA generated from non-treated (control) and poly(I:C) treated Xela DS2 or Xela VS2 
cells to determine relative transcript levels of ifn1 (A, B), mx2 (C, D), and pkr. For all 
experiments, transcript expression from treated samples was normalized to time matched 
control, (n = 5 independent trials). Significant differences were determined by a Mann-




also demonstrated a time-dependent increase in ifn1 transcript levels over 24 h post poly(I:C) 
treatment (Fig. 2.7B). At 6 h post poly(I:C) treatment, ifn1 transcript levels were 8.9 ± 6.3 
fold higher than the time matched non-treated control cells (Fig. 2.7B), although not 
statistically significant (p = 0.7937). By 12 h and 24 h post poly(I:C) treatment, ifn1 mRNA 
levels in Xela VS2 were 14.6 ± 8.4 fold (p = 0.0079) and 27.0 ± 14.8 fold higher (p 
=0.0159), respectively, than time-matched non-treated controls (Fig. 2.7B). Although the ifn1 
levels are not statistically different from the time-matched controls at 24 h post treatment, the 
p-value (p = 0.0159) is close to the cut-off (p < 0.0125). 
RT-qPCR was also used to determine transcript levels of the key downstream ISGs, 
mx2 and pkr, that are important in mediating antiviral programs in host cells in response to 
type I interferon by limiting viral transcription and viral translation respectively (Haller et al., 
2015; Williams, 1999). Over 24 h post treatment with poly(I:C), mx2 transcript levels did not 
significantly change in Xela DS2 cells (Fig. 2.7C). Similarly, no significant changes in mx2 
transcript levels occurred in Xela VS2 over the first 12 h post poly(I:C) treatment (Fig. 2.7D). 
However, by 24 h post treatment, a significant 2.8 ± 0.4 fold (p = 0.0079) increase in mx2 
transcripts were observed in Xela VS2 (Fig. 2.7D). In contrast to mx2 transcript levels, pkr 
transcript levels increased in Xela DS2 (Fig. 2.7E) and Xela VS2 (Fig. 2.7F) cells following 
poly(I:C) treatment. Xela DS2 showed a significant 5.8 ± 0.8 fold increase (p = 0.0079) in 
pkr transcript levels in response to poly(I:C) after 12 h, and this increase in transcript level 
was similar at 24 h, with a 6.2 ±0.4 fold increase (p = 0.0079) above time matched non-
treated controls (Fig. 2.7E). Transcripts for pkr were also up-regulated in a time-dependent 
manner in poly(I:C) treated Xela VS2 cells at all time points, reaching a 4.3 ± 0.7 fold 








Figure 2.8. Poly(I:C) treatment induces the upregulation of cytokine and chemokine 
transcript levels in Xela DS2 and Xela VS2. RT-qPCR was performed on cDNA 
generated from non-treated (control) and poly I:C treated Xela DS2 or Xela VS2 cells to 
determine relative transcript levels of tnf (A, B), il1 (C, D), il8 (E, F), and ikb (G, H). For 
all experiments, transcript expression from treated samples was normalized to the time 
matched control, (n = 5 independent trials). Significant differences were determined by a 




2.3.6. Treatment of Xela DS2 and Xela VS2 cells with poly(I:C) induces the up-
regulation of key proinflammatory cytokines 
To determine the whether the sensing of poly(I:C) by frog skin epithelial cells results 
in promoting a proinflammatory response, RT-qPCR was performed to examine potential 
changes in proinflammatory transcript levels in Xela DS2 and Xela VS2 in response to 
poly(I:C) treatment over 24 h. Xela DS2 and Xela VS2 both showed increases in tnf, il1, and 
il8 proinflammatory transcripts following poly(I:C) treatment (Fig. 2.8). Xela DS2 
demonstrated significant increases tnf (Fig. 2.8A) and il1 (Fig. 2.8C) transcript levels of 78.0 
± 26.4 fold (p = 0.0079) and 22.3 ± 6.5 fold (p = 0.0079), respectively, at 3 h post poly(I:C) 
treatment, and these increases in transcript levels persisted over the 24 h time period 
examined. A 75.7 ± 21.7 fold (p = 0.0079) increase in tnf mRNA levels (p = 0.0079; Fig. 
2.8B) and a 14.0 ± 0.1 fold (p = 0.0079) increase in il1 mRNA levels (p = 0.0079; Fig. 2.8D) 
were observed at 6 h post poly(I:C) treatment in Xela VS2 cells. Transcript levels of tnf and 
ilb remained significantly elevated in Xela VS2 relative to the time-matched, non-treated 
controls over the entire course of the experiment, with a 146.7 ± 64.7 fold (p = 0.0079) 
increase in tnf expression (Fig. 2.8B) and a 26.2 ± 5.8 fold (p = 0.0079) increase in il1 
expression (Fig. 2.8D) observed at 24 h post poly(I:C) treatment.  
As IL-8 is a potent chemokine and thus instrumental in recruiting innate immune cells 
(e.g. neutrophils) to the site of inflammation, I measured the relative change in il8 transcripts 
in Xela DS2 and Xela VS2 cells in response to poly(I:C) stimulation. Similar to the 
upregulation of proinflammatory cytokine gene expressions, a time-dependent increase in il8 
transcript levels were observed in Xela DS2 (Fig. 2.8E) and Xela VS2 (Fig. 2.8F) as early as 
3 h and 6 h post poly(I:C) treatment, respectively. By 24 h post treatment, il8 transcript levels 
reached 38.9 ± 5.6 fold (p = 0.0079) and 30.1 ± 4.9 fold (p = 0.0079) higher levels in 
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poly(I:C) treated Xela DS2 (Fig. 2.8E) and Xela VS2 (Fig. 2.8F), respectively, relative to 
time-matched, non-treated control cells.   
Finally, changes in ikb expressions in Xela DS2 and Xela VS2 following treatment 
with poly(I:C) were examined. Xela DS2 showed a significant 9.6 ± 1.8 fold (p = 0.0079) 
increase in ikb transcript levels by 3 h post treatment and these transcript levels were 
sustained throughout the 24 h treatment period (Fig. 2.8G). Similarly, a significant 8.6 ± 1.4 
fold increase (p = 0.0079) in ikb transcript levels were observed in Xela VS2 cells by 6 h post 
treatment, reaching 15.4 ± 4.6 fold higher transcript levels (p = 0.0079), relative to the time-
matched controls, by 24 h post treatment (Fig. 2.8H).  
2.4. Discussion 
2.4.1. Xela DS2 and Xela VS2 are skin epithelial-like cell lines 
Xela DS2 and Xela VS2 have been developed from the dorsal and ventral skin of 
adult African clawed frogs and are the first known skin epithelial-like cell lines to be 
produced from the adult of this important model organism. Although a number of cell lines 
have been developed from X. laevis, they are mainly derived from embryos (Sakaguchi et al., 
1989; Smith et al., 2002) or tadpoles (Anizet et al., 1981; Pudney et al., 1973), with only a 
handful of cell lines developed from adult frogs, mostly derived from tumors (Rafferty, 1965; 
Rafferty, 1969; Robert et al., 1994) or restricted to kidney tissue origin such as the A6 
(Rafferty, 1969) and XLK-WG (Martin et al., 1998) cell lines. Like other ectothermic 
vertebrate cell lines (Bols et al., 2017; Rafferty, 1969; Rausch and Simpson, 1988), Xela DS2 
and Xela VS2 arose spontaneously through sub-culturing efforts and have been passaged 
over 160 times within the past four years. Both Xela DS2 and Xela VS2 grow optimally at 
26°C; however, they are capable of growth over a much wider temperature range (14°C to 
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30°C) and thus excellent models for temperature-based research. Although Xela DS2 and 
Xela VS2 initially exhibited low levels of senescence associated beta-galactosidase activity 
at early passages, at higher passages beta-galactosidase activity was completely absent. In 
mammalian cells, beta-galactosidase enzyme activity is usually associated with cellular 
senescence and is rarely observed in quiescent or immortalized cells (Dimri et al., 1995), 
permitting beta-galactosidase activity to be used as a general indicator of cellular senescence 
in vivo and in vitro (Itahana et al., 2007). The long term and high proliferative capacity, 
together with the lack of beta galactosidase enzyme activity, supports the immortal nature of 
Xela DS2 and Xela VS2 cell lines.  
Xela DS2 and Xela VS2 cell lines display uniform epithelial-like cell morphology 
and express epithelial cell associated molecular markers (Chu and Weiss, 2002). Although 
Xela DS2 and Xela VS2 demonstrate differential krt5 expression and lack krt14 expression, 
both cell lines express krt19, a keratin subtype known to be expressed in highly permeable 
simple epithelium (Chu and Weiss, 2002). This coincides with the characteristic permeable 
nature of frog skin, as the epidermal layer is relatively thin compared to skin of other 
organism in order to achieve important physiological functions (Lillywhite, 2006). 
Furthermore, cytokeratin 19 has been implicated as a marker for skin stem cells that are 
necessary for continuous regeneration of skin layers and wound healing, and the presence of 
cytokeratin 19 has been identified in human skin cultures in vitro (Michel et al., 1996). 
Another hallmark of epithelial cells is the formation of cellular junctions, such as adherens 
and tight junctions. Both Xela DS2 and Xela VS2 express the cdh1 gene wherein the 
corresponding cadherin 1 protein, also known as epidermal cadherin, is involved in the 
formation of adherens junctions specifically between epithelial cells (Proksch et al., 2008; 
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van Roy and Berx, 2008). These cells also expressed cldn1 and ocln genes that are necessary 
for the formation of tight junctions between epithelial cells (Furuse et al., 1998; Tsukita and 
Furuse, 1999) with claudin 1 protein notably known to be important in mammalian epidermal 
barrier integrity (Furuse et al., 2002). The expression of these cellular junction genes is in 
accordance with the observed junctions apparent between cells in confluent Xela DS2 and 
Xela VS2 monolayers when viewed using phase contrast microscopy.  
Interestingly, Xela DS2 and Xela VS2 exhibit differential expression of col and vim 
molecular markers. Collagen genes are usually expressed by fibroblasts and the production of 
collagen proteins is important in the formation of the extracellular matrix (Groulx et al., 
2011). However, collagen genes are also expressed in epithelial cells (Creely et al., 1988), 
including mucosal associated epithelial cells (Birkedal-Hansen et al., 1982; Hayashi et al., 
1988; Ohji et al., 1994) or epithelial cells undergoing EMT (Hosper et al., 2013; Yang et al., 
2013). It is possible that a select population of Xela DS2 and Xela VS2 cells may be 
undergoing EMT as vim, a gene commonly expressed by mesenchymal cells (Chaw et al., 
2012; Mendez et al., 2010), was expressed in both cell lines. While my results indicate that 
Xela DS2 and Xela VS2 differentially express collagen genes, the synthesis and secretion of 
collagen proteins and formation of extracellular matrixes by these cells lines requires further 
investigation. Yet, the expression of tight and adherens junction protein transcripts, 
particularly cdh1, is strong evidence to support that Xela DS2 and Xela VS2 are epithelial-
like in nature, as cellular junctions are important for maintain epidermal integrity and cdh1 is 
known to be localized to epidermal cells (Farquhar and Palade, 1963; Proksch et al., 2008; 
van Roy and Berx, 2008). Collectively, these results, in conjunction with cell morphology, 
strongly support that Xela DS2 and Xela VS2 are epithelial-like in origin. Further in vivo 
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detection of these epithelial markers at the protein level is required before Xela DS2 and 
Xela VS2 can be deemed true epithelial cultures. Nonetheless, the establishment and 
characterization of Xela DS2 and Xela VS2 represent a key advancement in the generation of 
in vitro model systems for future investigations in amphibian skin epithelial cell biology, 
including environmental parameters that may impact epithelial cell characteristics such as 
cellular junctions and transepithelial resistance as a means of determining skin barrier 
integrity.   
2.4.2. Xela DS2 and Xela VS2 are capable of sensing and responding to 
extracellular dsRNA by initiating antiviral and proinflammatory programs 
Poly(I:C) treatment of mammalian epithelial cell cultures resulted in marked upregulation 
of TNF, IL-1β, IL-8, IFN1, and PKR gene expressions or protein production (Kinoshita et al., 
2009; Kumar et al., 2006). The upregulation of key proinflammatory cytokines tnf and il1 
was also observed in the teleost epithelial cell line EPC when treated with poly(I:C) 
(Holopainen et al., 2012). Xela DS2 and Xela VS2 had an immediate morphological 
response to poly(I:C) exposure, with many cells losing adherence to the cell culture vessel by 
3 h. Both cell lines had marked upregulation in key antiviral genes as well as 
proinflammatory cytokine transcripts, as expected based on other models studied (Baggiolini 
et al., 1989; Dinarello, 1996; Zelova and Hosek, 2013). The expression of il8 in Xela DS2 
and Xela VS2 suggests that frog skin epithelial cells may be capable of producing 
chemotactic factors necessary for the recruitment of immune cells. Xela DS2 and Xela VS2 
are thus able to upregulate key antiviral, proinflammatory, and chemokine programs 
responsible for the initiation and direction of an innate immune response to the site of 
infection via recruitment of innate immune cells. Furthermore, in mammalian models, Type I 
IFN binds to its cognate receptor on virus–infected or non-infected neighbouring host cells, 
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upregulating ISGs (Alsharifi et al., 2008; Schoggins and Rice, 2011) that play an integral role 
in the inhibition of viral replication and ultimately lead to viral clearance (Sen and Ransohoff, 
1993). Although there was no change in mx2 expression, the increase in pkr transcript levels 
for both Xela DS2 and Xela VS2 likely indicates that these cells are capable of ISG 
production to further drive host cellular antiviral mechanisms. Overall, my findings suggest 
potential conservation of the ability for epithelial cells across vertebrates to recognize and 
respond to dsRNA. The results shown here provide evidence that Xela DS2 and Xela VS2 
are capable of sensing extracellular dsRNA, as seen by changes in morphology and 
upregulation of transcript levels for key genes part of the antiviral and proinflammatory 
programs. This suggests that frog skin epithelial cells may be more than an inert physical 
barrier, potentially contributing to an inflammatory response similar to that observed in skin 
epithelial cells of human and mouse models (Gomez et al., 2013; Nestle et al., 2009). It is 
important to note, however, that further studies are needed to compare the results obtained 
using Xela DS2 and Xela VS2 cell lines with frog skin epithelial cell primary cultures as well 
as comparison to in vivo studies. 
Sensors of viruses in mammalian skin epithelial cells and teleost cells include Toll-
like receptors and scavenger receptors, particularly for their capacity to recognize dsRNA 
(Dieudonne et al., 2012; Köllisch et al., 2005; Poynter and DeWitte-Orr, 2018). The X. laevis 
genome encodes for TLRs and scavenger receptors, as well as several other mediators of 
viral infection such as IFN receptors (Ishii et al., 2007; Krause and Pestka, 2005). While 
there is some evidence to suggest that engagement of such receptors with their cognate 
ligands or viral nucleic acids generates a typical antiviral response in amphibians (Bird et al., 
2002; Krause and Pestka, 2005; Sun et al., 2010), the ability of frog skin epithelial cells to 
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detect and respond to viral pathogens remains poorly understood. In mammals, frogs and 
teleosts, class A scavenger receptors bind extracellular poly(I:C) or dsRNA and is believed to 
traffic extracellular dsRNA to endosomal TLR3 (Matsumoto and Seya, 2008; Poynter and 
DeWitte-Orr, 2018; Vo et al., 2019b). Although I have not identified the receptor(s) that 
recognize poly(I:C) on Xela DS2 and Xela VS2, my findings demonstrates that both cell 
lines are capable of sensing exogenous dsRNA and must express dsRNA-sensing surface 
PRRs that result in the robust upregulation of antiviral genes and proinflammatory genes in 
these cells. This may suggest that extracellular dsRNA in aquatic environments may be 
sensed by frog skin epithelial cells to initiate antiviral defences and confer a level of 
protection to the host. Finally, while this study examined the expression of an intron-
containing IFN, X. laevis is known to express a suite of intron and intron-less IFNs (Sang et 
al., 2016; Wendel et al., 2018) which should be further explored in Xela DS2 and Xela VS2. 
Frog skin epithelial cells are thus an important first line of defence in sensing pathogens and 




3. Chapter 3: Investigating the role of Xela DS2 and Xela VS2 in 
recognizing and responding to Frog Virus 3 
3.1. Introduction 
Emerging infectious diseases, such as Frog Virus 3 (FV3), are believe to be the 
proximate cause in the current worldwide decline in amphibian populations, with 43% of 
amphibian species experiencing some form of decline (Daszak et al., 2003; Stuart et al., 
2004). FV3 (family Iridoviridae, genus Ranavirus) is a large double-stranded DNA virus 
(Chinchar, 2002) and has recently been linked to mass die-offs events in ponds across North 
America (Gray et al., 2007; Greer et al., 2005). Frogs susceptible to FV3 exposure, such as R. 
sylvatica (Forzán et al., 2017) and R. catesbeiana (Miller et al., 2007), exhibit formation of 
skin lesions, swelling, internal hemorrhage, and while dependent on frog species, FV3 is 
known to induce necrosis and liquefaction of liver, spleen, renal tubule, hematopoietic tissue 
and lymphoid tissue (Forzán et al., 2017; Robert et al., 2005).  
Transmission of FV3 is believed to occur through direct animal contact, indirectly 
through the aquatic environment, or through the ingestion of FV3 containing organic material 
(e.g. cannabolism of infected individuals) (Lesbarreres et al., 2012). In the laboratory, 
infected adult X. laevis can transmit FV3 to healthy adult and larval frogs within 3 h of 
exposure through waterborne infectivity (Robert et al., 2011). As such, frog skin is an 
important interface between the frog’s internal milieu and the external environment and is 
likely the first line of defence against direct and indirect sources of environmental FV3. Skin 
tissue is multi-layered, but unlike in other vertebrae, frog skin has a relatively thin epithelial 
barrier layer (Varga et al., 2019). Though this aids in the provision of highly permeable frog 
skin necessary for physiological homeostasis (Lillywhite, 2006; Varga et al., 2019), it may 
also be disadvantageous as there is physically less barrier for pathogens to cross. Recent 
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studies in X. laevis suggest that Type I IFN responses in skin tissues play an integral role in 
the FV3 antiviral response wherein subcutaneous administration of Type I IFN into highly 
susceptible X. laevis tadpoles conferred short-term protection from FV3 infection (Wendel et 
al., 2017; Wendel et al., 2018). While skin is the first interface between a frog and its 
environment, it is important to also understand the contribution of individual frog skin 
epithelial cells in mediating a response meant to abrogate FV3 infection, such as 
participating in the initiation of antiviral programs. 
Studies conducted on understanding FV3 viral properties and virus-cell interactions 
have been done primarily in vitro. Albeit being largely performed in mammalian and fish cell 
lines, FV3 is known to induce a total shutdown of host cellular macromolecular synthesis 
whether live, heat-inactivated or UV-inactivated (Goorha and Granoff, 1974; Williams, 
1996). Investigation of FV3 infection in frog cells in vitro has been limited to immune cell 
(Koubourli et al., 2017; Morales et al., 2010), kidney (Andino Fde et al., 2015), or tadpole 
(Vo et al., 2019a). To date, no studies have looked at the interaction between FV3 and 
isolated frog skin epithelial cells. Therefore, the establishment of Xela DS2 and Xela VS2 
that are capable of responding to synthetic analogues of viral dsRNA (outlined in Chapter 2) 
affords an excellent opportunity to investigate the antiviral response of frog skin epithelial 
cells to FV3 exposure using these two cell lines as a model system. I hypothesized that Xela 
DS2 and Xela VS2 would be permissive to FV3 infection and be unable to initiate protective 
cellular antiviral or proinflammatory programs in response to FV3 infection. The first 
objective of this chapter was to evaluate whether Xela DS2 and Xela VS2 were permissive to 
FV3 and support viral replication. The second objective was to determine whether these cell 
lines initiate an antiviral response to FV3. The last objective was to determine if prior 
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initiation of antiviral programs in Xela DS2 and Xela VS2 would impact cellular 
cytopathicity and FV3 replication in infected cells. Herein, I report on Xela DS2 and Xela 
VS2 permissiveness to FV3, their inability to upregulate key antiviral, proinflammatory 
cytokine and chemokine gene transcripts in response to FV3 challenge, and the effectiveness 
of prior induction of an antiviral response through pre-treatment of cells with poly(I:C) on 
limiting FV3 replication. 
3.2. Methods 
3.2.1. Media 
For Xela cell lines, the preparation of complete media and APBS was performed as 
previously described in Chapter 2 Section 2.2.2.  Since viral binding and infection efficiency 
is hindered at high FBS concentrations (Petricevich et al., 2001), experiments involving FV3 
infection of Xela cell lines were performed using AL-15 supplemented with 2% FBS (VWR), 
herein referred to as Xela low serum media. Epithelioma Papulosum Cyprini (EPC) cells 
were maintained in L-15 (Wisent Inc.) supplemented with 10% FBS, herein referred to as 
EPC complete media. For FV3 applications using EPC cells, L-15 supplemented with 2% 
FBS was used and will be referred to as EPC low serum media. 
3.2.2. Cell culture maintenance  
The maintenance of Xela DS2 and Xela VS2 was performed as previously described 
in Chapter 2 Section 2.2.4. For all experiments herein, a plating efficiency of 79% for Xela 
DS2, 83% for Xela VS2 was taken into account when seeding cells. EPC cells were kindly 
provided by Dr. Niels Bols at the University of Waterloo. Although it is known that current 
EPC cell lineages were contaminated with fathead minnow cells, they are still deemed worth 
retaining as a cell line for the study of aquatic viruses (Winton et al., 2010). EPC cells were 
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selected since they have been widely used in the study of FV3 and in FV3 propagation (Ariel 
et al., 2009; Pham et al., 2015). EPC cells were maintained in T-75 cm2 plug-seal tissue-
culture treated flasks containing 10 mL of EPC complete media at 26°C. EPC cells were 
subcultured 1:4 every 5-7 days as follows: media was removed from the flask and cells 
washed with 6 mL of 1× PBS. Following the removal of PBS, 2 mL 0.25% trypsin-EDTA 
(Wisent Inc.) was added to detach cells from the cell culture vessel. Immediately following 
total cell detachment from the flask, 2 mL of EPC complete media was added to inactive 
trypsin prior to seeding at 1:4. Cells harvested from flasks were used in experiments by first 
centrifuging at 300 × g for 10 min and resuspension in fresh EPC complete media. EPC cells 
demonstrated 100% plating efficiency when enumerated the day after seeding.  
3.2.2.1. Cryopreservation of EPC cells 
Harvested EPC cells were used for cryopreservation as previously described in 
Chapter 2 Section 2.2.5 with the following changes: EPC cells were centrifuged at 300 × g 
for 10 min, and cells were resuspended to approximately 10-12 × 106 million cells per mL in 
chilled EPC complete media containing 10% DMSO. 
3.2.3. Propagation of FV3 in EPC cells 
FV3 (Granoff strain, ATCC VR-567) was a kind gift from Dr. Niels Bols at the 
University of Waterloo. FV3 was propagated in confluent EPC cells, known to be highly 
permissive to FV3 infection. EPC cells were maintained at 26°C in T-75 cm2 plug-sealed 
flasks containing EPC complete media. For FV3 propagation, 1 mL of stock FV3 was diluted 
in 9 mL of EPC low serum media and the entire volume placed on a confluent flask of EPC 
cells for 7 days at 26°C. At 7 days post infection (dpi), cell culture media from the flask of 
infected EPC cells was collected, centrifuged at 1000 × g for 10 min, filtered through a 0.22 
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µm PES filter (FroggaBio), then aliquoted into sterile 1.5 mL microfuge tubes for storage at -
80°C. Usually, stock FV3 aliquots were prepared by pooling cell culture media containing 
FV3 from five T-75 cm2 flasks, yielding ~ 50 mL of stock FV3.  
3.2.4. Determination of FV3 viral titre 
To determine viral stock titre, EPC cells were seeded in a 96-well plate (Thermo 
Scientific) at a final cell density of 100,000 cells/well in 0.1 mL EPC complete media and 
allowed to adhere overnight at 26°C. The next day, three FV3 stock tubes were removed 
from the -80°C freezer, pulse vortexed, and serially diluted by a factor of 1:10 up to 11 times 
(10-11) in EPC low serum media. EPC monolayers were exposed to 0.2 mL of diluted 
supernatant in octuplicate for 10 days at room temperature, where they were then scored for 
cytopathic effects (CPE). Viral titre was expressed as the tissue culture infectious dose 
wherein 50% of cells are infected (TCID50/mL), calculated from the plate scoring using the 
Karber method (Kärber, 1931), further described by (Pham et al., 2011). This protocol was 
also applied to experimental samples described below, with the following differences: diluted 
supernatants were added in quadruplicate and incubated for 7 days at room temperature. 
TCID50/mL was multiplied by a factor of 0.7 to determine the approximate FV3 PFU/mL for 
multiplicity of infection (MOI) calculations (Knudson and Tinsley, 1974).  
3.2.5. FV3 infection in early passage Xela DS2 and Xela VS2 cells to assess 
change in morphology  
Xela DS2 (passage 23) and Xela VS2 (passage 25) (N = 1) cells were seeded in a T-
25 cm2 plug-seal tissue-culture treated flasks (Thermo Scientific) at a final cell density of 6 × 
106 million cells/flask in 2 mL of Xela complete media allowed to adhere overnight at 26°C. 
The next day, Xela complete media was removed from flasks then cells were treated with 2 
mL of Xela low serum media alone (non-infected control), or containing FV3 at MOIs of 0.2, 
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2 or 20. After 2 h of incubation at 26°C, media was removed and wells washed 3 × 2 mL 
APBS, prior to the addition of 2 mL of fresh Xela low serum media to all wells. Phase 
contrast digital images were captured 24 hpi using a Nikon Eclipse TSX-100 fitted with a 
color camera and Picture Project software. 
3.2.6. RT-PCR for the detection of FV3 mcp transcripts in infected Xela DS2 
and Xela VS2 
Xela DS2 (passages 75-90) and Xela VS2 (passages 75-90) (N = 3) cells were seeded 
into a 6-well plate at a final cell density of 625,000 cells/well in 1 mL Xela complete media 
and allowed to adhere overnight at 26°C. The next day, cells were treated with 6.25 mL of 
low serum media alone (non-infected control), or containing FV3 at MOIs of 0.2 or 20, for 2 
h at 26°C. Afterwards, media was removed and wells were washed 3 × 1 mL APBS prior to 
the addition of 2 mL fresh Xela low serum media. Plates were then incubated at 26°C for the 
duration of the experiment. Cells were collected using a 1000 µL pipette tip as a cell scraper 
to gently detach adherent cells from wells into suspension at 12 and 24 hpi for cells 
challenged at MOI of 20, or 1 and 3 dpi for cells challenged with MOI of 0.2 FV3. Cell 
suspensions were centrifuged at 500 × g for 5 min and supernatant aspirated. Cell pellets 
were washed 1 × 500 µL APBS then centrifuged at 500 × g for 5 min to remove trace serum. 
RNA was isolated from the cell pellets using EZ-10 Spin Column Total RNA Minipreps 
Super Kit (Bio Basic Canada Inc.) and cDNA synthesized using SensiFAST cDNA Synthesis 
Kit (BioLine distributed by FroggaBio) as described previously in Chapter 2, Section 2.2.12. 
RT-PCR reactions consisted of (final concentrations) 2 mM MgCl2, 200 μM dNTP, 200 nM 
sense primer, 200 nM antisense primer (Sense: 5’-GACTTGGCCACTTATGAC-3’, 
Antisense: 5’-GTCTCTGGAGAAGAAGAA-3’), 0.625 U Taq DNA Polymerase, and 0.5 µL 
template made up to 25 μL reaction volumes with molecular grade water. Targets included 
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major capsid protein (mcp) viral transcripts from FV3 (Sense: 5’-
GACTTGGCCACTTATGAC-3’, Antisense: 5’-GTCTCTGGAGAAGAAGAA-3’) (Pham et 
al., 2015; Robert, 2015), and X. laevis actb (see Chapter 2 Table 2.2 for primer information) 
as an endogenous control. Molecular grade water used as a no template control. 
Thermocycling conditions were as follows: initial denaturation at 95°C, 5 min; 25 (actb) or 
35 (mcp) amplification cycles of denaturation at 95°C for 45 s, annealing at 55°C for 30 s, 
and elongation at 72°C for 45 s (actb) or 60 s (mcp), followed by a final extension step at 
72°C for 10 min. To each RT-PCR reaction, 5 µL of 6× loading buffer [0.1% xylene cyanol 
(ICN Biomedicals), 30% v/v glycerol (EMD Chemicals)) was added prior to loading into a 
1.4% agarose (VWR) gel containing 1× RedSafe Nucleic Acid Staining Solution (FroggaBio) 
and electrophoresed in 1× TAE buffer at 140 V for 20 min. Gels were imaged using a 
ChemiDoc imager (BioRad) with the Image Lab program.  
3.2.7. Alamar blue assay to assess cell adherence over FV3 infection of Xela 
cells 
Xela DS2 and Xela VS2 cells (passages 20-55) were seeded in a 48-well (Bio-Lite) 
plate at a final cell density of 50,000 cells/well in 0.2 mL Xela complete media and allowed 
to adhere overnight at 26°C. The next day, media was removed and then cells treated with 
0.25 mL of Xela low serum media alone (non-infected control), or containing FV3 at MOIs 
of 0.002, 0.02, 0.2, 2 or 20 in triplicate wells, alongside triplicate wells containing no cells as 
a background blank. After 2 h of incubation at 26°C, media was removed and wells washed 3 
× 300 μL before the addition of 500 μL of Xela low serum media. FV3-induced CPE was 
evaluated using an Alamar Blue (Life Technologies Inc) assay as a measurement of attached, 
viable cells remaining in the well. Alamar Blue is a commercial preparation of resazurin, 
which gets metabolically converted to a fluorescent compound for detection (Rampersad, 
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2012). A decrease in the cells’ ability to convert resazurin to its fluorescent counterpart 
means a decrease in cell metabolism, inferring a decrease in cellular health and thus cell 
viability (Rampersad, 2012). Resazurin assay was performed on 1, 3, 5 7, 10 and 14 dpi. The 
culture media was removed prior to the addition of 200 μL Alamar Blue solution, diluted 
1:20 with APBS, to each well. Plates were incubated for 1 h in the dark and read on a BioTek 
Synergy H1 plate reader, with excitation wavelength at 535 nm and emission wavelength at 
590 nm. Data was expressed as a fold change in fluorescence relative to the blank wells 
which contained no cells, representing a well wherein there was complete loss of cell 
adherence. 
3.2.8. Determining viral titre upon FV3 infection of Xela DS2 and Xela VS2  
Xela DS2 (earlier passages 30-50, later passages 129-139) and Xela VS2 (earlier 
passages 30-50, later passages 134-139) (N = 3 for early passage cells, N = 4 for later passage 
cells) cells were seeded in a 12-well plate (Thermo Scientific) at a final cell density of 
250,000 cells/well in 0.75 mL complete media and allowed to adhere overnight at 26°C. The 
next day, cells were collected by trypsin-EDTA from a triplicate set of sample wells, mixed 
1:1 with trypan blue (Invitrogen) and counted on a hemocytometer to accurately ascertain the 
number of cells present to calculate MOI from stock FV3. Complete media was removed 
from wells then cells were treated with 0.5 mL of low serum media alone (non-infected 
control) or containing FV3 at a MOI of 20 and 0.2 for early passage cells, or MOI of 20, 2, 
0.2, 0.02, and 0.002 for later passage cells. After 2 h of infection at 26°C, media was 
removed and wells washed 3 × 0.5 mL APBS, prior to the addition of 2.5 mL of fresh low 
serum media to all wells. For early cell passages, phase contrast digital images and cell 
culture media were collected on 0 (30 min post-wash), 1, 3, and 5 dpi for MOI of 20 FV3 
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challenge, and 0, 1, 3, 5, 7, 10, and 14 dpi for MOI of 0.2 FV3 challenge. Images were taken 
using a Nikon Eclipse TSX-100 fitted with a color camera and Picture Project software for 
early cell passages. Later cell passage phase contrast digital images and cell culture media 
were collected on 0, 1, 3, 5, and 7 dpi for all treatments; phase contrast digital images were 
captured using a Leica DMi1 microscope fitted with a MC170 color camera and LASX 4.8 
software. Collected cell culture media was centrifuged at 500 × g for 5 min, and supernatants 
transferred to sterile 1.5 mL microfuge tubes prior to storage at -80°C. Viral titre assay using 
EPC cells was performed as described in Section 3.2.4 with the following changes: for later 
passage titres, day 0 samples were serially diluted by a factor of 1:10 up to 4 times (10-4), up 
to 7 times (10-7) for day 1 samples, and up to 11 times (10-11) for day 3, 5, and 7 samples. 
3.2.9. Inactivation of FV3 via UV irradiation 
FV3 aliquots, stored in 1.5 mL microfuge tubes, were removed from -80°C and 
placed in a sealed transfer vessel (beaker with parafilm) lined with paper towel then allowed 
to thaw at room temperature. A paper towel was soaked with 70% ethanol then placed inside 
a UV Crosslinker (BioRad) to dry. Afterwards, FV3 aliquots were removed from the transfer 
vessel, mixed via gentle vortexing, then disinfected with 70% ethanol and left to dry on the 
paper towel in the UV crosslinker. Once dried, FV3 aliquots received a total of 150 mJ UV 
energy, a dose which has been previously used to effectively inactivate FV3 (Chinchar et al., 
2003). Tubes were placed evenly spaced from one another and in an identical spatial 
orientation to ensure each aliquot received identical treatment. Aliquots and the UV 
crosslinker was then disinfected with 70% ethanol, and aliquots stored at -80°C for future use. 
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3.2.10. Confirmation of UV-inactivation of FV3 using EPC cells via viral 
transcript detection and viral titre assay 
In order to verify UV-FV3 was effectively inactivated and incapable of replication, 
EPC cells were infected with both FV3 and UV-FV3 to assess viral transcription and titre. To 
detect the presence of the viral transcripts, EPC cells (passage 420) (N = 1) were seeded in a 
6-well plate (Thermo Scientific) at a final cell density of 800,000 cells/well in 1 mL EPC 
complete media and allowed to adhere overnight at 26°C. After 48 h, cells were exposed to 1 
mL of EPC infection media alone (non-infected control), UV-inactivated FV3 (MOI of 2), or 
FV3 (MOI of 2) in triplicate, for 2 h at 26°C. Afterwards, media containing treatments were 
removed from EPC monolayers and wells washed 3 × 1 mL APBS prior to the addition of 2 
mL fresh EPC infection media. Plates were incubated at 26°C for the duration of the 
experiment. A 1000 µL pipette tip was used as a cell scraper to lift adherent cells from a 
single well of each treatment into suspension at 24 hours post infection (hpi). Cell 
suspensions were centrifuged at 300 × g for 10 min and supernatant was removed. Cell 
pellets were washed 1 × 500 µL PBS then centrifuged at 300 × g for 5 min. RNA was 
isolated from the cell pellets using EZ-10 Spin Column Total RNA Minipreps Super Kit (Bio 
Basic Canada Inc.) and cDNA synthesized using SensiFAST cDNA Synthesis Kit (BioLine 
distributed by FroggaBio) as described in Chapter 2 Section 2.2.12. RT-PCR reactions 
consisted of (final concentrations) 2 mM MgCl2 (GeneDireX), 200 μM dNTP (GeneDireX), 
200 nM sense and antisense primers (Sigma), 0.625 U Taq DNA Polymerase (GeneDireX), 
and 0.5 µL of template made up to 25 μL reaction volumes with molecular grade water. 
Targets included FV3 mcp to evaluate viral transcript production, and EPC actb (Sense: 5’-
TGAAGATCCTGACCGAGAGA-3’, Antisense: 5’-GGATACCGCAAGACTCCATAC-3’) 
as an endogenous control. Molecular grade water used as a no template control. 
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Thermocycling conditions were as follows: initial denaturation at 95°C, 5 min; 30 (EPC actb) 
or 35 (mcp) amplification cycles of denaturation at 95°C for 45 s, annealing at 55°C for 30 s, 
and elongation at 72°C for 50 s (EPC actb) or 60 s (mcp), followed by a final extension step 
at 72°C for 10 min. To each RT-PCR reaction, 5 µL of 6× loading buffer [0.1% xylene 
cyanol (ICN Biomedicals), 30% v/v glycerol (EMD Chemicals)) was added prior to loading 
into a 1.4% agarose (VWR) gel containing 1× RedSafe Nucleic Acid Staining Solution 
(FroggaBio) and electrophoresed in 1× TAE buffer at 140 V for 20 min. Gels were imaged 
using a ChemiDoc imager (BioRad) with the Image Lab program. Detection of mcp was only 
detected in EPC cells infected with FV3 and not in UV-FV3 treated EPC. To detect the 
presence of infectious FV3 virions, cell supernatants from all treatments were collected from 
the remaining duplicate wells at 0 and 7 dpi, centrifuged at 500 × g for 5 min, and 
supernatants transferred to a sterile 1.5 mL microfuge tubes prior to storage at -80°C. Viral 
titre assays using EPC cells were performed as previously described (Section 3.2.4).  
3.2.11. Challenge of Xela DS2 and Xela VS2 with poly(I:C), UV-inactivated FV3, 
and FV3 
Xela DS2 (passages 120-130) and Xela VS2 (passages 125-135) (N = 4 independent 
trials) were seeded in a 6-well plate (Eppendorf) at a cell density of 625,000 cells/well in 1 
mL of Xela complete media and allowed to adhere overnight at 26°C. The next day, the 
media was removed and cells treated with 0.5 mL of Xela low serum media alone into two 
wells or containing UV-inactived FV3 (MOI of 2) into one well, and FV3 (MOI of 2) into 
one well. After 2 h at 26°C, media containing the various treatments was removed, wells 
washed 3 × 0.5 mL APBS, and replaced with 2 mL of fresh Xela low serum media to one of 
two Xela low serum treated wells, the UV-FV3 treated well, and FV3-infected well. 
Immediately after, 2 mL of fresh Xela low serum media containing 1 µg/mL poly(I:C) was 
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added to the remaining Xela low serum treated well (positive control). Phase-contrast images 
were taken of all treatments at 0, 6, 24, 48, and 72 h post treatment, which commenced 
following addition of fresh Xela low serum media, using a Leica DMi1 microscope fitted 
with a MC170 color camera and LASX 4.8 software to assess cell morphology. At each time 
point, cell supernatants from all treatments were collected and centrifuged at 500 × g for 5 
min to collect all cells. The supernatants were transferred to a sterile 1.5 mL microcentrifuge 
tube at stored at -80°C for later use (see Section 3.2.13). The cell pellet was used for total 
RNA isolation using the EZ-10 Spin Column Total RNA Minipreps Super Kit as described in 
Chapter 2 Section 2.2.12 with the following change: cell pellets were suspended in 100 µL 
lysis solution then mixed 1:1 with 70% ethanol and stored on ice. Meanwhile, remaining 
adherent cells were washed 1 × 1 mL APBS, followed by the addition of 300 µL lysis 
solution directly to wells for 1 min on ice, then mixed 1:1 with 70% EtOH. This was then 
transferred and mixed by inversion with cell pellet lysis extract prior to addition to spin 
columns. RNA quantity, purity, and integrity, and subsequent cDNA synthesis, were 
performed as described in Chapter 2 Section 2.2.12. The cDNA samples were stored at -20°C 
until use in RT-qPCR transcript analysis. 
3.2.12. Quantitative RT-PCR 
Primer sequences, accession numbers, R2 and primer efficiency values for X. laevis 
tnf, il1, il8, ikb, ifn1, mx2, pkr, actb, cyp, ef1a, gapdh, and hgprt were previously reported in 
Table 2.2, Chapter 2 Section 2.2.15. Prior to transcript analysis, gene stability testing was 
conducted for actb, cyp, ef1a, gapdh, and hgprt to permit selection of an endogenous control. 
To perform gene stability testing, cDNA samples across all trials generated from Section 
3.2.11 were pooled together in a time-matched and treatment-matched fashion and diluted 
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1:40 in molecular grade water. RT-qPCR reactions (10 µL volumes) were prepared in 
triplicated and consisted of (final concentrations) 500 nM sense and antisense primer, 5 µL 
PowerUp SYBR green mix (Thermo Scientific), and 2.5 µL of diluted cDNA template. 
Thermocycling conditions were as follows: initial denaturation at 50°C for 2 min, followed 
by 95°C for 2 min, 40 amplification cycles of denaturation at 95°C for 1 s, and extension at 
60°C for 30 s. A melt curve step followed all runs to ensure only a single dissociation peak 
was present, with initial denaturation at 95°C for 1 s, then dissociation analysis at 60°C for 
20 s followed by 0.1°C increments between 60°C and 95°C at 0.1°C/s. Gene stability 
measures (M-value) were determined for all endogenous control candidates using the 
Applied Biosystems QuantStudio Analysis software (Table 3.1), wherein a lower M-value 
infers stronger gene stability across time and treatment. The target selected for the 
endogenous control was actb, with M-value values at 0.428 and 0.424 for Xela DS2 and Xela 
VS2 respectively. 
For transcript analysis, RT-qPCR reactions were prepared in duplicate and consisted 
of 2.5 µL of 500 nM sense and antisense primers, 5 µL PowerUp SYBR green mix (Thermo 
Scientific), and 2.5 µL of diluted (1:20) cDNA template. The cycling conditions and 
dissociation analysis was performed as described above. Reactions were prepared in a 
MicroAmp fast optical 96-well reaction plates (Life Technologies), sealed with MicroAmp 
clear optical film (Life Technologies) and run on QuantStudio5 Real-Time PCR System 
(Thermo Scientific). Four independent trials were conducted using Xela DS2 and Xela VS2 




Table 3.1. Candidate endogenous genes for use in RT-qPCR analysis of FV3 infected 
Xela DS2 and Xela VS2 cells. 
Target 
Xela DS2  
M-Value 
Xela VS2  
M-Value 
actb 0.428 0.424 
cyp 0.393 0.440 
ef1a 0.479 0.600 
gapdh 0.434 0.462 
hgprt 0.462 0.534 
 
3.2.13. Detection of FV3 mcp transcripts in Xela cells to confirm UV-inactivation 
of FV3 
RT-PCR reactions for FV3 mcp consisted of buffer containing (final concentrations) 
2 mM MgCl2, 200 μM dNTP, 200 nM sense and antisense primers, 0.625 U Taq DNA 
Polymerase, 1 µL of template in a total volume of 25 μL. Templates consisted of molecular 
grade water (no template control), cDNA generated from EPC cells infected with FV3 at 
MOI of 2 after 24 hpi (see Section 3.2.6), or cDNA generated from Xela DS2 or Xela VS2 
infected with FV3 at MOI of 2 after 48, and 72 hpi (see Section 3.2.11) (N = 4). 
Thermocycling conditions were as follows: initial denaturation at 95°C, 5 min; 35 
amplification cycles of denaturation at 95°C for 45 s, annealing at 55°C for 30 s, and 
elongation at 72°C for 60 s, followed by a final extension step at 72°C for 10 min. To each 
RT-PCR reaction, 5 µL of 6× loading buffer (0.15% xylene cyanol, 30% v/v glycerol) was 
added prior to loading into a 1.5% Agarose gel containing 1× RedSafe Nucleic Acid Staining 
Solution and electrophoresed in 1× TAE buffer at 100 V for 30 min. Gels were imaged using 
a ChemiDoc imager (BioRad) with the Image Lab program. . 
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3.2.14. Viral titre of supernatants from UV-FV3 challenged and FV3-infected 
Xela DS2 and Xela VS2  
Collected cell supernatants from Section 3.2.11 were used to determine FV3 viral 
titres (N = 4). Viral titre assays using EPC cells were performed as previously described 
(Section 3.2.4) with the following changes: non-infected and poly(I:C) treated samples were 
diluted to 10-1, culture media from UV-FV3 challenged samples were diluted to 10-2, and 
culture media from FV3 challenged samples were diluted to 10-7 by a factor of 1:10 in EPC 
low serum media. TCID50/mL was calculated by scoring for CPE after 7 days at 26°C 
(Kärber, 1931; Pham et al., 2011). 
3.2.15.  Effect of poly(I:C) treatment and FV3 infection on suspension cell 
viability  
Xela DS2 (passages 135-140) and Xela VS2 (passages 138-143) cells were seeded in 
a 48-well (Thermo Scientific) plate at a final cell density of 50,000 cells/well in 0.3 mL Xela 
complete media and allowed to adhere overnight at 26°C. The next day, media was removed, 
and cells were pre-treated with 160 µL of Xela low serum media containing 0, 10, 50, or 100 
ng/mL poly(I:C) for 24 h, in sextuplicate. Following pre-treatment, 90 µL of low serum 
media alone was added to three of the six replicates for all treatments, or Xela low serum 
media containing FV3 (MOI of 2) added to the remaining triplicate 0, 10, 50, or 100 ng/mL 
poly(I:C) pre-treated wells. After incubation at 26°C for 2 h, supernatants from all poly(I:C) 
pre-treatments without FV3 were collected and while remaining media was removed from all 
wells, and washed 3× with 0.3 mL APBS prior to the addition of 0.5 mL of fresh Xela low 
serum media to all wells, placed at 26°C. Collected supernatants (26 h post-treatment) were 
centrifuged at 500 × g for 5 min, and cell pellets resuspended in 20 µL Xela low serum 
media. Cell suspensions were mixed 1:1 with trypan blue and live/dead cells enumerated 
using a hemocytometer under 400× brightfield using a Leica DMi1 microscope. A total of 
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200 cells were counted in multiple fields of view per-treatment. In addition to monitoring 
effects of poly(I:C) on suspension cell viability, supernatants were collected from all 
treatments at 5 dpi, centrifuged at 500 × g for 5 min, and pellets were resuspended in 20 µL 
Xela low serum media. Trypan blue exclusion assay was performed on cell supernatants as 
previously described. Three independent trials were performed for each set of experiments. 
3.2.16. Determining the effect of poly(I:C) pre-treatment on Xela DS2 and Xela 
VS2 cellular adherence via resazurin assay and cell enumeration of 
NucBlue Live stained cells 
This experiment was conducted in tandem with the experiment described in Section 
3.2.15. After 0, 3, 5 dpi, cell culture media was collected across 0, 10, 50, and 100 ng/mL 
poly(I:C) pre-treated samples, which were infected or non-infected with FV3, then 
centrifuged at 500 × g for 5 min and transferred to sterile 1.5 mL microfuge tubes prior to 
storage at -80°C for later determination of FV3 titre  (see Section 3.2.17). Afterwards, 
duplicate wells were treated with 200 µL of 440 µM resazurin (Acros Organics) solution 
dissolved in APBS and a single well treated with 200 µL Xela low serum media containing 
NucBlue Live reagent (ThermoFisher), which is a Hoechst stain, and incubated in the dark 
for 1 h. NucBlue Live was prepared by adding 1 drop of reagent per mL of Xela low serum 
media. Following the 1 h incubation, plates were read on BioTek Cytation5 imaging reader 
using Gen5 software under the following conditions: duplicate resazurin treated wells were 
read with excitation wavelength 535 nm and emission wavelength 590 nm, while single 
NucBlue Live treated wells were fluorescently imaged with excitation wavelength 377 nm 
and emission wavelength 477 nm to determine representative cell count for each respective 
treatment. Digital phase contrast images were capture in addition to fluorescent imaging of 
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NucBlue Live treated cells. Four independent trials were conducted, using cells from 
different passages for each trial. 
3.2.17. Monitoring the potential effect poly(I:C) pre-treatment has on FV3 viral 
titre in Xela DS2 and Xela VS2 
Collected cell supernatants from Section 3.2.16 were used to perform a titre analysis 
(N = 3). Viral titre assay using EPC cells was performed as previously described (Section 
3.2.4) with the following changes: regardless of poly(I:C) pre-treatment, non-FV3 challenged 
samples were diluted to 10-1 while FV3 challenged samples were diluted to 10-11 by a factor 
of 1:10 in EPC low serum media. TCID50/mL was calculated from the plate scoring using a 
modified Karber method (Kärber, 1931; Pham et al., 2011). 
3.2.18. Statistics 
Alamar blue assay (Section 3.2.7) data were analyzed by a two-way ANOVA test 
followed by a Tukey’s post-hoc test. RT-qPCR (Section 3.2.12) data were analyzed by a two-
way ANOVA followed by a Holm-Sidak post-hoc analysis. Viral titres from FV3 infected 
cells (Section 3.2.14), and poly(I:C) cytotoxicity and FV3 cytopathicity data (Section 3.2.15) 
were analyzed by a one-way ANOVA, followed by a Tukey’s post-hoc test. Effect of 
poly(I:C) pre-treatment on FV3 replication in Xela DS2 and Xela VS2 (adherence and FV3 
titres; Sections 3.2.16 and 3.2.17, respectively) were analyzed by a two-way ANOVA 
followed by a Tukey’s post-hoc test. Statistical analyses were performed using GraphPad 




3.3.1. Xela DS2 and Xela VS2 are permissive to FV3 and support viral 
replication 
To assess the effect of FV3 challenge on Xela DS2 (passage 23) and Xela VS2 
(passage 25) morphology, cells were monitored under phase-contrast after 24 h post infection 
(hpi) for cytopathic effects (CPE) (Fig. 3.1). Non-infected cells remained adherent to the cell 
culture vessel, retaining characteristic epithelial cell-to-cell contact (Fig. 3.1). After 24 hpi, 
there appeared to be no changes in cell morphology in Xela DS2 or Xela VS2 infected with 
FV3 MOI of 0.2 relative to the non-infected control (Fig. 3.1). Minor CPE are observed in 
both Xela DS2 and Xela VS2 infected with FV3 at a MOI of 2, wherein cell-to-cell contact 
and cell density appears to have decreased, accompanied with an apparent increase in non-
adherent, suspension cells (Fig. 3.1). CPE was most pronounced in Xela DS2 and Xela VS2 
infected with FV3 MOI of 20, wherein cells appear to contract followed by the loss of cell 
adherence to the cell culture vessel.  
To determine whether FV3 is capable of transcription in the host, the presence of mcp 
transcripts in FV3 challenged Xela DS2 and Xela VS2 were examined (Fig. 3.2). Transcripts 
for FV3 mcp were detected at 12 hpi and 24 hpi in both Xela DS2 and Xela VS2 infected 
with FV3 at a MOI of 20 (Fig. 3.2). In Xela DS2 and Xela VS2 cells infected with FV3 at a 
lower MOI of 0.2, mcp transcripts were detected as early as 1 d post infection (dpi) and mcp 
transcripts appeared to increase at 3 dpi (Fig. 3.2). To further ascertain whether Xela DS2 
and Xela VS2 could support FV3 replication and production of infectious virions, viral titre 





Figure 3.1. Effect of FV3 challenge on early passage Xela DS2 and Xela VS2 morphology. Phase contrast images of early 
passage Xela DS2 and Xela VS2 following challenge with FV3 at MOI of 0, 0.2, 2, or 20, monitored 24 hpi. Images were taken at 






Figure 3.2. FV3 major capsid protein transcripts are detected in Xela DS2 and Xela VS2 after FV3 infection. Gel 
electrophoresis image from RT-PCR of no template control (NTC), Xela DS2 and Xela VS2 non-infected control (C) and FV3 
infected (I) cells at a  multiplicity of infection (MOI) of 20 or 0.2 for FV3 major capsid protein (mcp) at 12  and 24 hpi or at 1 (D1) 




infected with FV3. At earlier passages (30-50) of Xela DS2 and Xela VS2 (Fig. 3.3), FV3 
viral titre appears to increase in a time-dependent and dose-dependent manner. At day 0, FV3 
titres are below the limit of detection for both cell lines infected with FV3 at a MOI of 0.2 
(Fig. 3.3). Titre values appear to reach a plateau by day 7, achieving log10(TCID50/mL) 
values of 6.5 ± 0.3 and 6.5 ± 0.1 for Xela DS2 and Xela VS2, respectively, with these titres 
persisting till day 14 (Fig. 3.3). When challenged with FV3 MOI of 20, viral particles were 
detected as early as day 0, with titre values of 3.3 ± 0.1 and 3.4 ± 0.1 for Xela DS2 and Xela 
VS2 respectively. Titres peaked by day 3 persisted up to day 5, reaching 6.5 ± 0.1 in Xela 
DS2 and 6.2 ± 0.4 in Xela VS2 at 5 dpi (Fig. 3.3). Similar peak viral titres were achieved in 
Xela DS2 and Xela VS2 by 5 dpi across varying FV3 MOIs (Fig. 3.3). 
 The loss of Xela DS2 and Xela VS2 cell adherence upon FV3 infection was identified 
as a characteristic FV3-induced CPE, wherein Alamar Blue assay was used to monitor the 
degree of loss in cellular adherence due to FV3 infection. Data was expressed as a fold-
change relative to blank wells absent of cells, thus representing a case of complete loss in cell 
adherence (Fig. 3.4). Therefore, a value of 1.0 would infer that all cells in the treatment lost 
adherence, and anything greater than 1.0 suggests active cellular metabolic activity from any 
remaining adherent cells. Both Xela DS2 (Fig. 3.4A) and Xela VS2 (Fig. 3.4B) showed 
similar trends, wherein there is a clear dose-dependent and time-dependent decrease in the 
number of adherent cells as confirmed by two-way ANOVA analysis. There were no 
significant differences between values in cells challenged with FV3 at MOI ≤ 0.02, and time-
dependent decreases in cell adherence in cells challenge with FV3 at MOI ≥ 0.2. Overall, the 
loss of cell adherence can be used as a proxy to monitor FV3-induced CPE in Xela DS2 and 





Figure 3.3. Xela DS2 and Xela VS2 are permissible to viral replication at early passages. Early passages (passages 30-50) of 
Xela DS2 and Xela VS2 cell line were infected with FV3 at a MOI of 20 or 0.2 and cell culture media collected over 5 or 14 days, 
respectively. Cell culture media from FV2-infected Xela DS2 and Xela VS2 were serially diluted and applied to a 96-well plate 
containing monolayer of EPC cells. EPC monolayers were scored for cytopathic effects (CPE) after 7 days to determine the 
TCID50/mL. Dashed lines represent projected TCID50/mL values as no CPE was observed at day 0 for Xela DS2 or Xela VS2 cells 
infected at MOI of 0.2. CPE were not observed in cell culture media from non-infected Xela DS2 and Xela VS2 cell lines at any 





Xela VS2 Xela DS2 
Figure 3.4. Xela DS2 and Xela VS2 lose adherence in response to infection with FV3. Early passages of (A) Xela DS2 and (B) 
Xela VS2 cell line were infected with FV3 at MOI of 20, 2, 0.2, 0.02, 0.002, and 0.0002 and CPE was monitored over 14 days via 
Alamar Blue assay using a BioTek Synergy H1 plate reader. Data is expressed as a fold change of fluorescence relative to blank 





3.3.2. Xela DS2 and Xela VS2 maintain susceptibility to FV3 at higher passages 
To assess the effect of FV3 challenge on Xela DS2 and Xela VS2 at later passages 
(129-139), cells were exposed to a range of FV3 MOIs and cells monitored for CPE using 
phase contrast microscopy over 7 days. While non-infected Xela DS2 (Fig. 3.5A) and Xela 
VS2 (Fig. 3.5B) cell monolayers become slightly more compact with time, no changes in cell 
morphology or adherence associated with CPE were observed. In general, both Xela DS2 
(Fig. 3.5A) and Xela VS2 (Fig. 3.5B) exhibited similar dose- and time-dependent CPE 
following FV3 infection, characterized by cell contraction and loss of adherence to the cell 
culture vessel resulting in large floating cell clumps in the cell culture media. Xela DS2 
exhibited signs of CPE, characterized by loss of cell adherence, by day 1 at MOIs of 20 and 2, 
by day 3 at MOI of 0.2, and by day 5 at MOI of 0.02 (Fig. 3.5A). For Xela VS2, initial signs 
of CPE were observed by day 1 for MOIs of 20 and 2, and by day 3 at MOIs of 0.2 and 0.02 
(Fig. 3.5B). In contrast to higher MOIs, no CPE were observed when Xela DS2 (Fig. 3.5A) 
or Xela VS2 (Fig. 3.5B) were challenge with FV3 at MOI 0.002. These morphological 
observations at higher MOIs were accompanied with increasing viral titre values in a time-
dependent and dose-dependent manner (Fig. 3.6). No viral particles were detected in non-
FV3 treated samples. Viral particles were detected as early as day 0 for Xela DS2 at MOI of 
0.02, 0.2, 2, and 20 (Fig. 3.6A) and for VS2 at MOI of 0.002, 0.02, 0.2, 2, and 20 (Fig. 3.5B). 
These viral titres increase in a time-dependent manner with viral titre levels peaking at day 5-
7 post infection (Fig. 3.6), reaching a maximal titre similar to that observed in the early 
passage cells (Fig. 3.3). While Xela DS2 and Xela VS2 largely support viral replication, FV3 
appears unable to effectively replicate at MOI of 0.002 (Fig. 3.6). 
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  Figure 3.5A. Effect of FV3 challenge on Xela DS2 morphology. Phase contrast images of Xela DS2 following challenge with 
FV3 at MOIs of 0, 0.002, 0.02, 0.2, 2, or 20, monitored over 7 days. Images were taken at 200× magnification using a Leica DMi1 





Figure 3.5B. Effect of FV3 challenge on Xela VS2 morphology. Phase contrast images of Xela VS2 following challenge with 
FV3 at MOIs of 0, 0.002, 0.02, 0.2, 2, or 20, monitored over 7 days. Images were taken at 200× magnification using a Leica DMi1 






Figure 3.6. Xela DS2 and Xela VS2 are permissible to viral replication across a 
range of MOIs. Viral titres in cell culture media from (A) Xela DS2 and (B) Xela VS2 
following infection with FV3 at MOIs of 0, 0.002, 0.02, 0.2, 2, and 20, performed at 
passages 129-139 and 134-139 for Xela DS2 and Xela VS2 respectively. Cell culture 
media collected from FV3-infected cells were serially diluted and applied to EPC 
monolayers and scored for cytopathic effects after 7 days to determine the TCID50/mL. 
Cytopathic effects were not observed in cell culture media from non-infected Xela DS2 




3.3.3. Xela DS2 and Xela VS2 do not initiate antiviral or proinflammatory 
transcript upregulation when challenged with UV-inactivated FV3 or FV3 
Xela DS2 and Xela VS2 were monitored for changes in cellular morphology over 72 
h following exposure to Xela low serum media alone or containing 1 µg/mL poly(I:C), UV-
inactivated FV3 at MOI of 2, or FV3 at MOI of 2. The cell monolayer appears to become 
slightly more compact for the non-treated control cells in Xela DS2 (Fig. 3.7A) and Xela 
VS2 (Fig. 3.7B). For both Xela DS2 and Xela VS2, initial loss of cell adherence is observed 
by 6 h in poly(I:C) treated cells, with cells continuing to lose adherence up to 72 h (Fig. 3.7). 
There is an initial change in cellular morphology upon UV-FV3 and FV3 challenge at 6 h in 
Xela DS2 and Xela VS2, as cell monolayers appear more disordered (Fig. 3.7). Loss of 
adherence is observed by 24 h in UV-FV3 and FV3 challenged cells, which progresses up to 
72 h where not many cells remain adherent (Fig. 3.7).  
I wanted to determine whether FV3, in an active or inactivated state, was able to 
promote an antiviral response in Xela DS2 and Xela VS2. RT-qPCR was performed to 
monitor any changes in antiviral transcript levels in Xela DS2 and Xela VS2 challenged with 
FV3 and UV-FV3 at MOI of 2, using treatment of Xela DS2 and Xela VS2 with 1 µg/mL 
poly(I:C) as a positive control (Fig. 3.8). No significant changes in ifn1 or mx2 transcript 
levels relative to time-matched controls occurred in Xela DS2 (Fig. 3.8A, C) or Xela VS2 
(Fig. 3.8B, D) over the 72 h period, regardless of treatment. There appeared to be a 
significant effect of poly(I:C) treatment only on Xela DS2 ifn1 expression (p = 0.0062), but 
there was no time-dependent effect (p = 0.9485) or significant interaction between time and 
treatment (p = 0.9935). However, significantly higher pkr transcript levels were detected in 
Xela DS2 (Fig. 3.8E) and Xela VS2 (Fig. 3.8F) in poly(I:C) stimulated cells (p < 0.0001) and 




Figure 3.7A. Xela DS2 lose adherence when treated with poly(I:C), UV-inactivated 
FV3 or FV3. Phase-contrast images of Xela DS2 when treated with media alone, 1 
µg/mL poly(I:C), UV-inactivated FV3 at MOI of 2, and FV3 at MOI of 2. Cellular 
morphology was monitored at 0, 6, 24, 48, and 72 hpi by capturing phase contrast images. 
Images were taken at 200× magnification using a Leica DMi1 microscope, scale bar is 




  Figure 3.7B. Xela VS2 lose adherence when treated with poly(I:C), UV-inactivated 
FV3 or FV3. Phase-contrast images of Xela VS2 when treated with media alone, 1 
µg/mL poly(I:C), UV-inactivated FV3 at MOI of 2, and FV3 at MOI of 2. Cellular 
morphology was monitored at 0, 6, 24, 48, and 72 hpi by capturing phase contrast images. 
Images were taken at 200× magnification using a Leica DMi1 microscope, scale bar is 




Figure 3.8. Xela DS2 and Xela VS2 do not upregulate antiviral transcripts following 
challenge with UV-inactivated FV3 or FV3. RT-qPCR was performed using cDNA 
generated from non-treated (media), 1 µg/mL poly I:C treated (pIC), UV-FV3 challenged 
at MOI of 2 and FV3 infected at MOI of 2 Xela DS2 or Xela VS2 cells to determine 
relative transcript levels of ifn1, mx2, and pkr. For all experiments, transcript levels from 
treated samples were normalized to time-matched, non-treated control. Data represent the 
mean  standard error, n = 4 independent experiments. Asterisks (*) indicate significant 
differences in transcript levels relative to the time-matched control, determined by a two-
way ANOVA and Holm-Sidak post-hoc test (p < 0.05). 
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in pkr transcript levels were observed in UV-FV3 and FV3 challenged cells. I then assessed 
whether Xela DS2 and Xela VS2 initiate proinflammatory programs in response to FV3. I 
previously demonstrated that Xela DS2 and Xela VS2 upregulate proinflammatory 
transcripts in response to 10 µg/mL poly(I:C) stimulation (Chapter 2, Section 2.3.6). A 
similar response is observed when Xela DS2 and Xela VS2 are treated with 1 µg/mL of 
poly(I:C), wherein a significant upregulation in il1 (Fig. 3.8A, B), tnf (Fig. 3.9C, D), il8 (Fig. 
3.9E, 3F), and ikb (Fig. 3.9G, H) transcript levels are seen. Although Xela DS2 and Xela 
VS2 can sense and initiate proinflammatory programs upon poly(I:C) stimulation, UV-FV3 
or FV3 challenge does not appear to induce Xela DS2 and Xela VS2 proinflammatory gene 
expressions (Fig. 3.8).  
3.3.4. UV-inactivated FV3 is not capable of replication in Xela DS2 or Xela VS2 
To verify that UV-FV3 was inactivated and incapable of replicating in Xela DS2 and Xela 
VS2, I assessed viral transcription and viral titres in Xela DS2 and Xela VS2 challenged with 
UV-FV3. Transcripts for mcp were detected in FV3 infected EPC cells (positive control), and 
in infected Xela DS2 and Xela VS2 cells but was not detectable in UV-FV3 FV3 challenged 
samples (Fig. 3.10A). Inactivation of UV-FV3 was further confirmed by performing titre 
analysis on collected cell supernatants. Although CPE were observed from incubation with 
UV-FV3 supernatants, 2-way ANOVA analysis unveiled that there is no change in these titre 
values over time. Meanwhile, titre values from FV3-treated supernatants increase in a time-
dependent manner and is always significantly higher than UV-FV3 treated titres. The 
presence of CPE in EPC monolayers treated with UV-FV3 supernatant is likely a similar 
effect as observed when Xela DS2 and Xela VS2 underwent CPE in response to UV-FV3 






Figure 3.9. Xela DS2 and Xela VS2 do not initiate proinflammatory programs 
following addition of UV-inactivated FV3 or FV3. RT-qPCR was performed on cDNA 
generated from non-treated (media), 1 µg/mL poly I:C treated (pIC), UV-FV3 challenged 
at MOI of 2 and FV3 infected at MOI of 2 Xela DS2 or Xela VS2 cells to determine 
relative transcript levels of il1, tnf, il8, and ikb.  For all experiments, transcript expression 
from treated samples was normalized to time matched non-treated control. Data represent 
the mean  standard error, n = 4 independent experiments. Significant differences (*) 
indicate significant upregulation in transcript expression relative to the time matched 




Figure 3.10. Confirmation of UV-FV3 inactivation via RT-PCR and titre analysis. 
(A) Gel electrophoresis image from RT-PCR of no template control (NTC), Xela DS2 and 
Xela VS2 non-infected control (M), poly(I:C) treated (P), UV-FV3 challenged at MOI of 
2 (ΔF) and FV3 infected at MOI of 2 (F) cells for FV3 mcp at 48 and 72 hpi. EPC cells 
infected with FV3 at MOI of 2 was used as a positive control. Cell culture media was 
collected across all treatments at all time points for Xela DS2 (B) and Xela VS2 (C), 
serially diluted and applied to EPC monolayers and scored for cytopathic effects after 7 
days to determine the TCID50/mL. Cytopathic effects were not observed in cell culture 
media from non-infected or poly(I:C) stimulated Xela DS2 and Xela VS2 cell lines at any 
time point, with minimal cytopathic effects observed in UV-FV3 challenged cells. Data 
represent the mean  standard error, n = 4 independent experiments. Significant 
differences were determined by a one-way ANOVA and a Tukey’s post-hoc test (p < 
0.05), wherein like lettering indicates no statistical significance between groups. 
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as viral replication is inhibited, demonstrated by the absence of viral transcript production in 
tandem with no increasing viral titre. 
3.3.5. Evaluating poly(I:C) cytotoxicity in Xela DS2 and Xela VS2  
Prior to selection of a poly(I:C) dosage to test the effect of poly(I:C) pre-treatment on 
FV3 infection, I first ascertained whether poly(I:C) treatment is cytotoxic to Xela DS2 and 
Xela VS2. This was done through a trypan blue exclusion assay under the principle that live 
cells have intact cellular membranes which would exclude trypan blue, while dead cells have 
an impaired cellular membrane thus allowing for the uptake of trypan blue (Strober, 2001). 
For Xela DS2, there is a significant dose-dependent relationship of poly(I:C) treatment with 
cell viability (p = 0.0002). While there are no significant differences between 0, 10, 50, or 
100 ng/mL poly(I:C) treatment, there is a significant decrease in percent cell viability Xela 
DS2 cells treated with 1,000 ng/mL (p = 0.0027) or 10,000 ng/mL (p = 0.0005) relative to the 
non-treated control (Fig. 3.11A). Similarly, a significant dose-dependent relationship was 
observed in Xela VS2 (p < 0.0001), wherein treatment of cells with 1,000 ng/mL (p < 0.0001) 
or 10,000 ng/mL (p < 0.0001) poly(I:C) yielded a significant decrease in percent cell 
viability relative to the non-treated control (Fig. 3.11B). Although further confirmation is 
required, it appears that poly(I:C) is more cytotoxic to Xela VS2 than Xela DS2 based on the 
difference in magnitude of percent cell viability between the two cell lines at the higher 




Figure 3.11. High concentrations of poly(I:C) appear cytotoxic to Xela DS2 and Xela VS2. Viability of (A) Xela DS2 and (B) 
Xela VS2 cells that had lost adherence to the culture vessel were assessed 24 hpt with 0, 10, 50, 100, 1,000, or 10,000 ng/mL 
poly(I:C) using Trypan blue. Suspension cells were collected from cell culture media by centrifugation, mixed 1:1 with trypan blue 
and cell viability assessed on a hemocytometer under brightfield microscopy, wherein a total of 200 cells were enumerated. Data 
represent the mean  standard error, n = 3 independent experiments. Significant differences were determined by a one-way 
ANOVA and a Tukey’s post-hoc test (p < 0.05), wherein like lettering indicates no statistical significance between groups. 
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3.3.6. Poly(I:C) pre-treatment confers partial protection against FV3-induced 
CPE in Xela DS2 and Xela VS2 
To assess the potential effects of poly(I:C) pre-treatment on FV3-induced CPE in 
Xela DS2 and Xela VS2, cells were pre-treated with 0 ng/mL, 10 ng/mL, 50 ng/mL or 100 
ng/mL for 24 h before FV3 infection (MOI of 2) and viability of adherent and suspension 
cells assessed over 5 dpi. These poly(I:C) concentrations were selected because they were 
not cytotoxic to Xela DS2 or Xela VS2 and did not affect cell adherence to the tissue culture 
vessel. NucBlue Live staining was used to visualize the number of adherent cells in wells of 
the tissue culture vessel. No change in the cell population is seen in Xela DS2 (Fig. 3.12A) or 
Xela VS2 (Fig. 3.12B) in poly(I:C) treated, non-infected cells over the 5 d experiment. Minor 
CPE (loss of cell adherence, thus decreasing the presence of stained nuclei) was observed on 
day 3 for Xela DS2 (Fig. 3.11A) at 0 and 10 ng/mL pre-treatment, while CPE was observed 
at all poly(I:C) concentrations for Xela VS2 with 100 ng/mL being the least severe (Fig. 
3.12B). By day 5, clear CPE was observed in FV3 infected cells with no poly(I:C) pre-
treatment as there was a complete loss in the presence of NucBlue Live-stained nuclei, but 
adherence was unaffected in both Xela DS2 (Fig. 3.12A) and Xela VS2 (Fig. 3.12B) for all 
poly(I:C) treated, non-infected wells. Nonetheless, poly(I:C) pre-treatment was able to 
mitigate FV3-induced CPE in a dose-dependent manner, at 100 or 50 ng/mL poly(I:C) in 
Xela DS2 (Fig. 3.12A) and 100 ng/mL for Xela VS2 (Fig. 3.12B). This trend was identical in 
phase contrast images of cells, wherein there was a poly(I:C) dose-dependent protection 
against FV3-induced CPE in both Xela DS2 (Fig. 3.13A) and Xela VS2 (Fig. 3.13B) 
monolayers. Additionally, cellular morphology appears unchanged between control wells, 




Figure 3.12A. Pre-treatment of Xela DS2 with poly(I:C) mitigate FV3-induced cytopathic effects. Fluorescence microscopy 
of NucBlue Live-stained Xela DS2 pre-treated with 0, 10, 50, or 100 ng/mL poly(I:C) for 24 h followed by FV3 infection at MOI 
of 2. Cellular morphology was monitored 0, 3, and 5 dpi. The BioTek Cytation 5 imaging reader was used to capture sixteen 40 × 







Figure 3.12B. Pre-treatment of Xela VS2 with poly(I:C) mitigate FV3-induced cytopathic effects. Fluorescence microscopy of 
NucBlue Live-stained Xela VS2 pre-treated with 0, 10, 50, or 100 ng/mL poly(I:C) for 24 h followed by FV3 infection at MOI of 
2. Cellular morphology was monitored 0, 3, and 5 dpi. The BioTek Cytation 5 imaging reader was used to capture sixteen 40 × 






Figure 3.13A. Monitoring Xela DS2 morphology from poly(I:C) pre-treatment followed by FV3 infection. Phase-contrast 
microscopy of Xela DS2 cells pre-treated with 0, 10, 50, or 100 ng/mL poly(I:C) for 24 h followed by FV3 infection at MOI of 2. 
Cellular morphology was monitored 0, 3, and 5 dpi using the BioTek Cytation 5 imaging reader; scale bar is 50 µm. Images shown 






Figure 3.13B. Monitoring Xela VS2 morphology from poly(I:C) pre-treatment followed by FV3 infection. Phase-contrast 
microscopy of Xela VS2 cells pre-treated with 0, 10, 50, or 100 ng/mL poly(I:C) for 24 h followed by FV3 infection at MOI of 2. 
Cellular morphology was monitored 0, 3, and 5 dpi using the BioTek Cytation 5 imaging reader; scale bar is 50 µm. Images shown 




In order to quantify the FV3-induced loss of cell adherence, the number of remaining 
adherent Xela DS2 (Fig. 3.14A) and Xela VS2 (Fig. 3.14B) cells were counted via NucBlue 
Live-stained nuclei enumeration, to determine the relative cell count ratio. Two-way 
ANOVA analysis indicated that there was a significant effect due to time (p < 0.0001) and 
poly(I:C) pre-treatment concentration (p < 0.0001), accompanied with a significant 
interaction between theses two factors (p < 0.0001), on Xela DS2 and Xela VS2 adherence 
monitored through NucBlue Live-stained nuclei enumeration. It appears that while there is 
no significant change in cell number among control wells and poly(I:C) treated, non-infected 
wells, poly(I:C) pre-treatment helps mitigate FV3-induced CPE in Xela DS2 (Fig. 3.14A) 
and Xela VS2 (Fig. 3.14B), in a dose-dependent manner. Furthermore, Xela DS2 appears 
more sensitive and better capable of conferring protection to FV3 challenge upon poly(I:C) 
pre-treatment than Xela VS2. While 100 and 50 ng/mL poly(I:C) pre-treatment appears to 
completely mitigate FV3-induced CPE in Xela DS2 (Fig. 3.14A), Xela VS2 was completely 
protected only when pre-treated with 100 ng/mL poly(I:C) (Fig. 3.14B).  
These effects were further confirmed by using resazurin assay as a proxy to infer the 
presence of viable adherent cells and thus monitor the degree of loss in cell adherence. Two-
way ANOVA analysis indicated that there was a significant effect due to time (p = 0.0004 for 
Xela DS2, p < 0.0001 for Xela VS2) and poly(I:C) pre-treatment concentration (p = 0.0159 
for Xela DS2, p = 0.0002 for Xela VS2), accompanied with a significant interaction between 
theses two factors (p = 0.0308 for Xela DS2, p < 0.0001 for Xela VS2), on Xela DS2 and 
Xela VS2 adherence monitored via resazurin assay. For both Xela DS2 (Fig. 3.14C) and Xela 
VS2 (Fig. 3.14D), there was no significant change in relative absorbance ratio values across 




Figure 3.14. Pre-treatment of Xela DS2 and Xela VS2 with poly(I:C) mitigates FV3-
induced loss in cell adherence. Xela DS2 and Xela VS2 cells were pre-treated with 0, 
10, 50, or 100 ng/mL poly(I:C) for 24 h before infecting cells with FV3 at MOI of 2 
alongside non-treated controls. On 0, 3, and 5 dpi, cell culture media was removed and 
adherent Xela DS2 (A) and Xela VS2 (B) NucBlue Live-stained nuclei were enumerated 
using the Cytation 5 plate reader. Resazurin assay was also performed on Xela DS2 (C) 
and Xela VS2 (D) to monitor metabolic-based viability. Data represent the mean  
standard error, n = 3 independent experiments. The viability of non-adherent cells were 
monitored at 5 dpi via trypan blue exclusion assay in (E) Xela DS2 and (F) Xela VS2. 
Data represent the mean  standard error, n = 4 independent experiments. Significant 
differences were determined by a two-way ANOVA and a Tukey’s post-hoc test (p < 





assay data is similar to the observed changes in morphology and nuclei counts: pre-treatment 
with 50 and 100 ng/mL poly(I:C) is able to abrogate FV3-induced CPE in Xela DS2 (Fig. 
3.14C) while 100 ng/mL poly(I:C) abrogates FV3-induced CPE in Xela VS2 (Fig. 3.14D).  
Trypan blue exclusion assay was also performed to assess the effect of FV3 challenge 
on suspension cell viability, as the assessment of these cells would have been excluded from 
DAPI-staining counts and resazurin assay experiments. Two-way ANOVA analysis indicated 
that there was a significant effect due to both FV3 (p < 0.0001) and poly(I:C) pre-treatment 
concentration (p = 0.0005 for Xela DS2, p < 0.0001 for Xela VS2) on Xela DS2 and Xela 
VS2 FV3-induced CPE, accompanied with a significant interaction between these two 
factors (p < 0.0001). In general, FV3 seems to impact Xela DS2 (Fig. 3.14E) and Xela VS2 
(Fig. 3.14F) suspension cell viability, but poly(I:C) pre-treatment is able to mitigate this 
effect in a dose-dependent manner. As such, both the adherent and suspension Xela DS2 and 
Xela VS2 cells respond to poly(I:C) pre-treatment by conferring partial resistance to FV3-
induced CPE.  
3.3.7. Poly(I:C) pre-treatment limits FV3 viral replication in Xela DS2 and Xela 
VS2 
To determine whether poly(I:C) pre-treatment limits FV3 replication, Xela DS2 or 
Xela VS2 were pre-treated with low serum media alone or containing 100 ng/mL poly(I:C) 
for 24 h prior to infection of cells with FV3. Viral titre analysis was performed on sample 
supernatants at 0, 3 and 5 dpi (Fig. 3.15). Two-way ANOVA analysis indicated that there 
was a significant effect due to time (p < 0.0001) and poly(I:C) pre-treatment concentration (p 
< 0.0001 for Xela DS2, p = 0.0106 for Xela VS2), accompanied with a significant interaction 
between theses two factors (p < 0.0001 for Xela DS2, p = 0.0063 for Xela VS2), on Xela 





Figure 3.15. Poly(I:C) pre-treatment reduces viral titre in Xela DS2 and Xela VS2. Cell culture media was collected from (A) 
Xela DS2 and (B) Xela VS2 when pre-treated with 0 or 100 ng/mL poly(I:C) then challenged with FV3 at MOI of 2, at 0, 3, and 5 
days post infection. Cell supernatants were serially diluted then applied to a 96-well plate containing a monolayer of EPC cells. 
Monolayers were scored for cytopathic effects after 7 days determine the TCID50/mL. Data represent the mean  standard error, n 
= 3 independent experiments. Significant differences were determined by a two-way ANOVA and a Tukey’s post-hoc test (p < 




100 ng/mL is able to limit FV3 replication in both Xela DS2 (Fig. 3.15A) and Xela VS2 (Fig. 
3.15B), which is in accordance with the observed trends from changes in cell morphology 
and analysis of FV3-induced CPE wherein 100 ng/mL poly(I:C) pre-treatment completely 
abrogated FV3-induced CPE. While the viral titre from non-poly(I:C) pre-treated Xela DS2 
(Fig. 3.15A) and Xela VS2 (Fig. 3.15B) increased in a time-dependent manner, there was no 
significant difference in titre levels between cells pre-treated with 100 ng/mL poly(I:C) at 
day 5 and cells from non-poly(I:C) pre-treated cells at day 0. However, for Xela VS2 (Fig. 
3.15B), there was a significant increase in the day 3 poly(I:C) pre-treated viral titre value 
relative to day 0 non-poly(I:C) pre-treated cells which then decreased back to baseline value 
(Fig. 3.15B).  
3.4. Discussion 
3.4.1. Xela DS2 and Xela VS2 are permissive to FV3 and support viral 
replication  
Xela DS2 and Xela VS2 cells infected with FV3 exhibit CPE wherein cells appear to 
shrink and contract then lose adherence to the cell culture vessel. This has also been observed 
in mammalian and fish cell lines, as well as the X. laevis A6 kidney epithelial cell line 
(Chinchar et al., 2003; Pham et al., 2015). A number of studies have identified apoptosis as a 
mechanism of cell death upon cellular FV3 infection in a various cell lines across vertebrates 
(Chinchar et al., 2003; Morales et al., 2010; Pham et al., 2015). However, other cell lines 
appear to lose viability through non-apoptosis driven mechanisms (Jancovich et al., 2015). 
While the mechanisms of cell death in FV3-infected Xela DS2 and Xela VS2 was not 
examined in this study, preliminary assessments of cell viability using trypan blue suggest 
the loss of membrane integrity and could be indicative of late apoptotic cells or pyroptosis. 
Regardless of the mechanism of cell death following FV3 infection, the loss of cell 
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adherence can be used as a proxy to estimate viral infection via a resazurin assay, wherein 
the degree of metabolic activity is proportional to the number of remaining viable cells that 
are adherent to the tissue culture vessel. Although metabolic activity may be altered in 
response to external stimuli leading to a potential under-representation of cell populations, 
decreases in metabolic function would indicate a negative impact on cellular health in 
general (Rampersad, 2012). In these situations, it is recommended that the resazurin assay is 
coupled with an additional assay to generate a more accurate prediction of the system, such 
as directly monitoring cell numbers (Rampersad, 2012). As such, coupling the resazurin 
assay with NucBlue Live-stained nuclei enumeration is an effective measure of FV3-induced 
CPE in terms of the loss of cellular adherence. Further studies are required to understand 
how/if Xela DS2 and Xela VS2 metabolism is impacted from poly(I:C) and/or FV3 treatment, 
the mechanism of the loss of cellular adherence, and confirmation of whether these cells are 
undergoing cell death. 
Xela DS2 and Xela VS2 appear equally permissible to FV3, supporting viral 
transcription and replication in a dose and time-dependent manner. While Xela DS2 and Xela 
VS2 are generally susceptible to FV3 at higher MOIs (≥ 0.02), no CPE is observed when 
infected with FV3 MOI of 0.002. This suggests that Xela DS2 and Xela VS2 have viral 
restriction to FV3. Interestingly at this lower MOI, infectious particles are detected earlier in 
infection which then appears to be cleared with time, although further investigation is 
required. Increases in viral titre and the detection of mcp in infected Xela DS2 and Xela VS2 
show that these cell lines are permissive to FV3 alongside mammalian and fish cells used in 
FV3 studies (Ariel et al., 2009; Braunwald et al., 1985; Pham et al., 2015; Vo et al., 2019a), 
albeit to varying degrees. The viral titre plateau for a number of rainbow trout cell lines was 
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reported at log10(TCID50/mL) 4-5, versus Xela DS2 and Xela VS2 at  log10(TCID50/mL) 6-7, 
and EPC at log10(TCID50/mL) 8-9 (Ariel et al., 2009; Pham et al., 2015) demonstrating the 
different replicative capacity of FV3 across cell lines. To my knowledge, the lower limit 
tolerance of cell lines to FV3 has not been previously studied. By showing that Xela DS2 and 
Xela VS2 are permissible to FV3 infection, it is likely that individual frog skin epithelial 
cells are susceptible to FV3, allowing infection to propagate through the skin. Further studies 
must be conducted to better elucidate the various mechanisms performed in the FV3-frog 
skin epithelial cell interaction, wherein Xela DS2 and Xela VS2 serve as suitable models. 
3.4.2. Xela DS2 and Xela VS2 do not upregulate antiviral or proinflammatory 
genes in response to FV3 
While Xela DS2 and Xela VS2 can recognize, are permissive to and support FV3 
viral replication, they appear to be unable to initiate antiviral or proinflammatory programs in 
the presence of FV3. Similarly, both cell lines failed to initiate these programs in response to 
UV-FV3, yet UV-FV3 is unable to undergo viral replication. Although I cannot rule out the 
upregulation of other antiviral genes, such as the ~30 other ifn transcripts (Sang et al., 2016; 
Wendel et al., 2018), the ~1000 ISGs, or other proinflammatory cytokines, my results 
suggest FV3 is likely enacting immunoevasion strategies of these frogs skin epithelial-like 
cell lines. FV3 is known for shutting down macromolecular synthesis in mammalian and fish 
cell lines (Goorha and Granoff, 1974), and select viral genes have been identified as 
possessing immune evasion properties against mammalian, fish, and amphibian (kidney A6) 
cell lines (Andino Fde et al., 2015; Jacques et al., 2017). This has also been shown to occur 
in cells challenged with FV3 that was heat-treated or UV-inactivated (Williams, 1996), 
which may explain the similar response between FV3 and UV-FV3 challenged Xela DS2 and 
Xela VS2. It is currently theorized that FV3 carries a capsid protein that is responsible for the 
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rapid shutdown of host antiviral pathways (Jacques et al., 2017; Rothenburg et al., 2011). 
While there is no documentation of the effect of UV inactivation of FV3 immunoevasion 
ability, I predict that UV inactivation does not impact FV3’s ability to elicit immunoevasion 
strategies since the protein would remain intact. Although further study is required, it appears 
as though the ability for FV3 to elicit immunoevasion strategies and induce total shutdown of 
host cellular machinery may be no different in Xela DS2 and Xela VS2. To my knowledge, 
this is the first report of potential immunoevasion elicited by FV3 in isolated frog skin 
epithelial-like cells, yet further studies must be conducted to further elucidate the FV3-frog 
skin epithelial cell interaction. 
3.4.3. Poly(I:C) pre-treatment of Xela DS2 and Xela VS2 mitigate FV3 
replication 
Xela DS2 and Xela VS2 appear to have a dose-dependent response to poly(I:C) 
treatment, wherein treatment at 10 µg/mL appears to yield a greater fold-change in gene 
expression for all transcripts studied (see Chapter 2, Sections 2.3.5 – 2.3.6) relative to 
treatment at 1 µg/mL (see Section 3.3.3). Regardless of treatment with 10 or 1 µg/mL 
poly(I:C), a significant number of Xela DS2 and Xela VS2 lose adherence, and only a single 
preliminary trypan blue exclusion assay with 10 µg/m poly(I:C) treatment demonstrated that 
cells were likely dying. Analysis of Xela DS2 and Xela VS2 cytotoxicity to poly(I:C) 
uncovered the degree of sensitivity of these cells to poly(I:C) exposure. Of the poly(I:C) 
concentrations studied, only those ≤ 100 ng/mL did not induce significant cellular 
cytotoxicity. Xela DS2 and Xela VS2 are then included among cell lines which respond to 
low poly(I:C) dose (Poynter et al., 2019; Tohyama et al., 2005), opposed to those which have 
been studied in concentrations ranges which would otherwise be cytotoxic to Xela DS2 and 
Xela VS2 (Kumar et al., 2006; Ritter et al., 2005). Given this sensitivity, it is important that 
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future studies involving the use of poly(I:C) as an immunostimulant in Xela DS2 and Xela 
VS2 are performed at low dosage levels. It was observed that treatment of mammalian 
neonatal keratinocyte cells with 25,000 ng/mL poly(I:C) induced cell death via pyroptosis 
(Lian et al., 2012). I have already demonstrated that Xela DS2 and Xela VS2 have a robust 
proinflammatory response when treated with poly(I:C), which is a known hallmark of 
pyroptotic cells—programmed cell death induced by a high inflammation state (Bergsbaken 
et al., 2009). As such, it is possible that Xela DS2 and Xela VS2 undergo pyroptosis in 
response to high dose poly(I:C) treatment but must be further studied to be confirmed. 
In response to poly(I:C) pre-treatment, both Xela DS2 and Xela VS2 demonstrated a 
protective effect against FV3-induced CPE at low poly(I:C) levels (≤ 100 ng/mL) in a dose-
dependent manner, in tandem with limiting the capability for FV3 to replicate. Given that 
poly(I:C) is a known Type I IFN inducer, and my current gene expression studies (see 
Chapter 2 Section 2.3.5; Chapter 3 Section 3.3.3) demonstrate that ifn1 and ISG transcripts 
are being upregulated in Xela DS2 and Xela VS2, it is likely that poly(I:C) stimulation 
induces an antiviral program in these cells to better prepare and protect from FV3 infection. 
This induction and protective effect appears to be stronger in Xela DS2 than Xela VS2, due 
to its ability to induce a protective effect at lower poly(I:C) levels. When these cells were 
previously exposed to a high dose of 10 µg/mL poly(I:C), most Xela DS2 innate immune 
transcripts examined were upregulated sooner than those in Xela VS2 (see Chapter 2, section 
2.3.5). It is proposed that this sensitivity is being captured, as the 24 h pre-treatment period 
may be enough time to induce a protective antiviral state in Xela DS2 but not as effective in 
Xela VS2. However, the exact mechanism to confer resistance to FV3 infection due to 
poly(I:C) pre-treatment is not known and should be further investigated. Nonetheless, the 
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initial poly(I:C)-induced immunogenic burst was enough to allow for not only protection of 
the cell monolayer and limiting/reducing viral titre , but also for the reduction in the number 
of non-viable suspension Xela DS2 and Xela VS2 cells when challenged with FV3 
demonstrating complete resistance to FV3 cytopathicity. It is important to note that the 
trypan blue exclusion assay may provide inference about whether cells are live or dead, but 
further analysis is required to support my findings such as exploring mechanisms of cell 
death. 
Previous studies on FV3 infection, as well as infection with other aquatic viruses, in 
fish cells have shown that poly(I:C) pre-treatment effectively mitigates viral-induced CPE in 
tandem with limiting viral replication (Lisser et al., 2017; Poynter and DeWitte-Orr, 2018; 
Poynter et al., 2019). However, my findings are the first study to demonstrate the 
effectiveness of an immunostimulant on mitigating FV3-induced CPE and limiting viral 
replication in isolated frog skin epithelial-like cells. Although FV3 may elicit 
immunoevasion properties to inhibit the induction of an antiviral program in Xela DS2 and 
Xela VS2, which is consistent with the literature (Andino Fde et al., 2015; Jacques et al., 
2017), my research shows evidence that FV3 is unable to break an antiviral program at not 
only the tissue level (Wendel et al., 2017), but also the cellular level. In conclusion, frog skin 
epithelial cells are permissive to FV3 as seen by CPE and inability to initiate antiviral and 
proinflammatory programs, but CPE can be mitigated when treated with an immunostimulant 




4. Chapter 4: Conclusions and Future Directions  
4.1. Overview and significance of findings 
Despite being faced with declines in amphibian populations wherein FV3 is believed 
to be a driving force (Daszak et al., 2003; Stuart et al., 2004), FV3-cellular interactions and 
mechanisms of infection in frog cells, such as eliciting immunoevasion strategies or 
induction of cell death, remain poorly understood. Frog skin is an important interface 
between the frog’s external and internal environment and is likely the first organ to encounter 
environmental pathogens, with surface layer epithelial cells acting as an important physical 
barrier limiting entry (Varga et al., 2019). However, the role of frog skin epithelial cells in 
recognizing and responding to FV3 is unknown. My thesis focuses on bridging this 
knowledge gap through the generation of novel X. laevis skin epithelial-like cell lines, Xela 
DS2 and Xela VS2. These cell lines were characterized after establishment, and with 
successive passages became stable cell lines for the in vitro study of isolated frog skin 
epithelial cells. Treatment of Xela DS2 and Xela VS2 with poly(I:C) (an analogue of viral 
dsRNA), although cytotoxic at high doses, induces transcript expression of antiviral and 
proinflammatory genes, demonstrating the ability of frog skin epithelial cells to sense and 
respond to viral dsRNA. The induction of this complement of genes was not observed when 
Xela DS2 and Xela VS2 are challenged with FV3 or UV-FV3, leading to obvious signs of 
cytopathicity characterized by cell contraction and subsequent loss of cellular adherence 
properties. Nonetheless, FV3-induced CPE and replication were capable of being mitigated 
in Xela DS2 and Xela VS2 with poly(I:C) pre-treatment. The implications of my findings are 
further discussed below, accompanied with potential future directions this work can be taken 
based on my results.  
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4.2. Frog skin epithelial cells are capable of recognizing and responding to 
extracellular viral dsRNA 
Treatment of Xela DS2 and Xela VS2 with poly(I:C) induces morphological changes 
and robust increases in immune gene transcripts. There is a clear dose-dependent sensitivity 
of Xela DS2 and Xela VS2 to poly(I:C), where relatively high doses (≥ 1000 ng/mL) induces 
the loss of cellular adherence and appears to be cytotoxic. This alone shows that Xela DS2 
and Xela VS2 are capable of the extracellular recognition and response to dsRNA, 
potentially through a SR family member (DeWitte-Orr et al., 2010; Limmon et al., 2008; Vo 
et al., 2019b), which is a feature not present in all cell types demonstrating the sensitivity of 
frog skin epithelial cells to extracellular dsRNA. In relation to the whole animal, skin 
shedding is common in amphibians for maintaining optimal physiological performance or in 
response to stress such as pathogen insult (Pessier, 2002; Weldon et al., 1993). As such, the 
loss of cellular adherence in Xela DS2 and Xela VS2 of may be reflective of skin shedding in 
response to external stimuli but needs to be further investigated. Nonetheless, poly(I:C) 
treatment of Xela DS2 and Xela VS2 induces the upregulation of antiviral (ifn1, pkr), and 
proinflammatory (tnf, il1, il8) genes, although the mechanism and specific PRR engagement 
is not known. The induction of these set of genes is dose-dependent, as treatment with 
poly(I:C) at 10 µg/mL (Chapter 2) yields a greater magnitude fold-change in gene expression 
for all transcripts studied than compared to treatment with 1 µg/mL (Chapter 3). To my 
knowledge, this work is the first study to confirm the ability for isolated frog skin epithelial-
like cells to sense and respond to a viral dsRNA analogue, as seen by potent upregulation of 
antiviral and proinflammatory gene transcripts under poly(I:C) treatment. Whether increased 
transcript levels correspond to protein synthesis of these targets in Xela DS2 and Xela VS2 is 
unknown. Similarly, poly(I:C) treatment of mammalian epithelial cell cultures resulted in 
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marked upregulation of TNF, IL-1β, IL-8, IFN1 and Mx gene expression and protein 
production (Kinoshita et al., 2009; Kumar et al., 2006). The upregulation of key 
proinflammatory cytokines tnf and il1 was also observed in the teleost epithelial cell line 
EPC when treated with poly(I:C) (Holopainen et al., 2012). These suggest potential 
conservation of the ability for epithelial cells across species to recognize and respond to 
dsRNA. 
4.3. Immunoevasion properties of FV3 are retained in frog skin epithelial 
cells, but can be overcome with prior induction of antiviral programs 
Xela DS2 and Xela VS2 are shown to be permissive to FV3 and viral replication, as 
seen by CPE, detection of viral mcp transcripts, and time and dose-dependent increases in 
viral titre in infected cells. These cell lines also incur CPE from UV-FV3 treatment, but 
without accompanying increase in titre levels or mcp detection. Although Xela DS2 and Xela 
VS2 demonstrate the ability to recognize FV3 and UV-FV3, there was no change in antiviral 
ifn1, mx2, pkr and proinflammatory tnf, il1, il8, and ikb transcript levels. The ability for FV3, 
whether active or UV-inactivated, to shut-down cellular molecular synthesis and elicit 
immune evasion strategies in mammalian and fish cells (Andino Fde et al., 2015; Chen et al., 
2011; Goorha and Granoff, 1974; Jacques et al., 2017) appears to be conserved in Xela DS2 
and Xela VS2. This may in part be due to the contribution of FV3 genes which have been 
identified as eliciting immune evasion strategies against mammalian, fish, and amphibian 
cells (Andino Fde et al., 2015; Jacques et al., 2017). Such genes include 18K, 52L, 64R, and 
viF2α (Andino Fde et al., 2015; Chen et al., 2011; Jacques et al., 2017). Nonetheless, I have 
demonstrated that pre-treatment of Xela DS2 and Xela VS2 with poly(I:C) allows for initial 
upregulation of proinflammatory and antiviral programs which effectively mitigate FV3-
induced CPE and limits viral replication from occurring. My studies thus show that while 
117 
 
FV3 is capable of host macromolecular shutdown and immune evasion, FV3 does not appear 
to be able to break an antiviral state once already induced. 
FV3 possesses a 100 kb genome which is composed of 95-100 ORFs as identified in 
in wild isolate strains (Morrison et al., 2014), but the exact function of each corresponding 
protein is unkown. The most well documented FV3 immune invasion protein is vIF2α, 
sharing homology with eukaryotic initiation factor 2α, and is an agonist to host-cell PKR 
(Rothenburg et al., 2011). Yet unlike other ranaviruses, the N-terminal PKR binding domain 
appears truncated in FV3 vIF2α, rendering the role of vIF2α unknown in FV3 (Chen et al., 
2011). Nonetheless, vIF2α-knockout mutant FV3 strains was still met with decreased levels 
of infectivity as well as viral titres levels (Chen et al., 2011). So while the role of FV3 vIF2α 
remains to be confirmed, it will be assumed that its immune evasion strategy is PKR-
dependent like other ranaviruses. Suppression of PKR would render the cell incapable of 
halting viral transcripts from undergoing transcription, so if there were an overabundance of 
PKR initially present, the cells could potentially overcome agonistic vIF2α. As such, one 
potential mechanism of protection from poly(I:C) pre-treatment may be that Xela DS2 and 
Xela VS2 produce PKR in an overabundance to limit vIF2α-mediated effects, wherein Xela 
DS2 may be more efficient at sooner producing PKR than Xela VS2. Many alternative 
proteins may exist which suppress host immune responses, such as 18K, 52L, and 64R 
(Jacques et al., 2017), but the function of these proteins must be better elucidated first. 
4.4. Novel frog skin epithelial-like cell lines for use as in vitro models 
While a handful of X. laevis cell lines do currently exist, they do not necessarily 
provide a system to study the initial interaction between the environment and amphibian. 
With the generation of Xela DS2 and Xela VS2, which are epithelial-like in nature, we can 
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now begin to elucidate this interaction and better understand the role of skin epithelial cells 
in frog host defence to a number of threats. Although Xela DS2 and Xela VS2 have been 
generated for their use in understanding the role of frog skin epithelial cells in sensing and 
responding to viral PAMPs and interaction with FV3, their use is not limited to these 
applications. Indeed, these cell lines can be utilized to answer a wide range of questions, such 
as understanding the impact of various stressors on frog skin epithelial cell immune 
mechanisms or barrier integrity in relation to the whole animal. Extensive studies have been 
conducted to better understand the impacts of our changing environment on frog populations, 
and have concluded that amphibians are sensitive to changes in temperature, increased UV 
radiation, and environmental stressors like chemical contaminants (Blaustein et al., 2010b; 
Hayes et al., 2002; Kerby et al., 2010; Todd et al., 2011). These demonstrate that stressors 
may render a host immunocompromised and susceptible to infection with a virulent pathogen 
(Blaustein et al., 2010a; Blaustein et al., 2003; Sifkarovski et al., 2014). Thus, Xela DS2 and 
Xela VS2 can be used to monitor the potential effects of multiple stressors on frog skin 
epithelial cells, such as use in toxicity screens. For example, atrazine exposure affected larval 
and adult X. laevis antiviral immunity, which can now be studied at the cellular level using 
Xela DS2 and Xela VS2 (Sifkarovski et al., 2014). Furthermore, since these cell lines are 
epithelial-like in nature and the expression of cellular junctions at the transcript level was 
identified, we can begin to look at how the expression of these junctions, and thus barrier 
integrity, may be impacted from environmental stressors. Yet, further in vitro analysis for the 
identification of these junction proteins in Xela DS2 and Xela VS2 must be performed to 
confirm that these cell lines are epithelial cells, and not just epithelial-like. 
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Immunoevasion mechanisms by FV3 can be confirmed in Xela DS2 and Xela VS2; 
although this can be studied in other cell lines as seen in A6 (Andino Fde et al., 2015), this 
would allow for the further elucidation of molecular mechanisms of FV3 immune evasion at 
the frog skin epithelial barrier. I propose this is important to look at because while many cell 
lines are highly susceptible to FV3 infection, Xela DS2 and Xela VS2 are currently the only 
cell lines which reports a lower limit resistance to FV3 infection which may be controlled by 
cellular antiviral mechanisms. This was seen by a net reduction of viral titres over time with 
FV3 infection at MOI of 0.002. As such, overall study of Xela DS2 and Xela VS2 with FV3 
at MOI ≤ 0.002 should be investigated to see whether ISGs and thus viral restriction genes 
are being turned on in the host, and may be useful in understanding the kinetics between viral 
and host gene transcripts and how one may outcompete the other. It is clear that the decline 
in amphibian species is due to a combination of factors, but there are limited studies showing 
this multi-factorial impact on amphibian hosts (Longo and Zamudio, 2017; Rollins-Smith, 
2017; Sifkarovski et al., 2014). Thus, the generation of Xela DS2 and Xela VS2 will act as 
important in vitro system for studying amphibian host-pathogen interactions at the skin 
epithelial interface in tandem with the impact of our changing environment. Xela DS2 and 
Xela VS2 will prove to be novel models for better understanding the interface between a frog 
and its environment. 
4.5. Future Directions 
4.5.1. Mechanism of Xela DS2 and Xela VS2 cell death from FV3 challenge 
While CPE was observed in Xela DS2 and Xela VS2 in response to poly(I:C), UV-
FV3, and FV3, the mechanism of cell death is unknown. The uptake of trypan blue by cells 
with a compromised cell integrity indicates that the cell is non-viable but does not unveil the 
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mechanism of cellular death. As such, the decrease in Xela DS2 and Xela VS2 viability from 
poly(I:C) or FV3 treatment should be further explored in order to understand what programs 
are being initiated in the host cell. For poly(I:C), a study found that cell death was induced in 
mammalian keratinocytes from high-dose poly(I:C) treatment via pyroptosis (Lian et al., 
2012). Pyroptosis is a form of programmed cell death which, in mammals, is partly 
dependent on the caspase-1-dependent induction and activation of IL-1β and IL-18 
(Bergsbaken et al., 2009). I previously demonstrated that high-dose poly(I:C) is potent to 
Xela DS2 and Xela VS2, yielding a strong upregulation in proinflammatory transcripts 
including il1. As such, Xela DS2 and Xela VS2 should be monitored for pyroptosis upon 
poly(I:C) treatment. For FV3, numerous studies have already identified that cells undergo 
apoptosis upon FV3 challenge, regardless if the cell is of mammalian, fish, or amphibian 
origin (Chinchar et al., 2003; Morales et al., 2010; Pham et al., 2015). Whether Xela DS2 and 
Xela VS2 undergo apoptosis from FV3 infection must be confirmed. Although the viability 
of Xela DS2 and Xela VS2 suspension cells from UV-FV3 treatment was not monitored, 
apoptosis was found to be induced in mammalian and fish cells regardless if treated with 
FV3, heat-inactivated FV3, or UV-FV3 (Chinchar et al., 2003), suggesting that this may be 
the same for isolated frog skin epithelial cells but requires confirmation. Elucidating the 
mechanism of cell death from these treatments in Xela DS2 and Xela VS2 will help to better 
understand the FV3-frog skin epithelial cell interaction and how FV3 may bypass the skin 
barrier at the cellular level. 
4.5.2. Screening Xela DS2 and Xela VS2 for the expression of dsRNA and 
dsDNA sensors and pattern recognition receptors 
The ability for Xela DS2 and Xela VS2 to recognize poly(I:C), FV3, and UV-FV3 is 
a good indication that these cells possess dsRNA sensors and PRRs necessary for at least the 
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recognition of extracellular pathogenic particles. Previously, SR-As have been shown to 
sense and bind dsRNA in mammalian, fish, and frog cells and are believed to be important in 
FV3 binding and mediating cell entry (DeWitte-Orr et al., 2010; Limmon et al., 2008; Vo et 
al., 2019a; Vo et al., 2019b). As such, SR family expression, identification and activity in 
Xela DS2 and Xela VS2 may help infer how these cells recognize poly(I:C) and FV3. These 
studies have also highlighted the importance of SRs in mediating cellular entry of poly(I:C) 
and FV3 (DeWitte-Orr et al., 2010; Vo et al., 2019a). The presence of internal dsRNA PRRs 
in Xela DS2 and Xela VS2 should also be investigated. It is known that dsRNA is produced 
during the FV3 life cycle (Doherty et al., 2016), yet the interaction between intracellular 
dsRNA sensors and FV3-derived dsRNA in frogs remains unknown. A number of internal 
cellular PRRs have previously been identified in mammalian and fish models which 
recognize viral dsRNA, including endosomal TLR3, cytosolic MDA5, RIG-I, and NLRs 
(Poynter et al., 2015; Zhou et al., 2014). The screening of Xela DS2 and Xela VS2 for viral 
dsRNA sensors would be insightful in understanding which members are potentially 
responsible for the recognition and response to viral pathogens.  
While a number of cytoplasmic DNA sensors exist (Paludan and Bowie, 2013), a 
novel cytosolic DNA sensor has recently been identified which is comprised of two parts: 
PAMP-recognizing cyclic GMP-AMP synthase (cGAS) and cell signalling Stimulator of 
Interferon Genes (STING), creating the cGAS-STING system (Diner et al., 2013; Sun et al., 
2013). This system is well documented in mediating the recognition of cytosolic dsDNA 
(from virus, bacteria, or necrotic cells) by cGAS to catalyze ATP and GTP to 2’,3’-cGAMP, 
then activating STING which is the member responsible for the induction of NF-κB and 
IRF3 (Chen et al., 2016).  A recent study has elucidated the role of dsDNA poxvirus immune 
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nucleases (poxins) in inhibiting the cGAS-STING system leading to 2’,3’-cGAMP 
degradation, thus eliciting immune evasion strategies (Eaglesham et al., 2019). Additionally, 
RNase III nuclease has been identified in the ranavirus Ambyostoma tigrinum virus, and 
although noted to be involved in suppressing fish cellular immunity, the impact of this or 
other viral nucleases on the cGAS-STING system is unknown. As such, it would be 
interesting to see whether novel nucleases are encoded by the FV3 genome, or other 
ranaviruses, which may be used to elicit immunoevasion strategies through bypassing the 
cGAS-STING system.. This may be a potential mechanism being utilized by FV3 to elicit 
immunoevasion in Xela DS2 and Xela VS2; release of putative nucleases by FV3 may 
inhibit host cGAS-STING-like system, suppressing the initiation of antiviral and 
proinflammatory pathways. This would be circumvented by poly(I:C) pre-treatment as Xela 
DS2 and Xela VS2 become challenged with FV3 when the systems are already well into the 
induction of antiviral and proinflammatory programs, successfully inhibiting viral replication. 
However, this is just speculation, confirmation of these events would begin with the 
identification of cGAS-STING system expression in Xela DS2 and Xela VS2, and 
identification of putative nucleases in FV3. Overall, the ability for Xela DS2 and Xela VS2 
to induce antiviral and proinflammatory programs appear to be turned off from FV3 and UV-
FV3 treatment, wherein mechanisms of immunoevasion should be further explored. 
4.5.3. Effect of poly(I:C) post-treatment on FV3 infection and replication in 
Xela DS2 and Xela VS2 
Pre-treatment of Xela DS2 and Xela VS2 with poly(I:C) resulted in the reduction of 
FV3-induced CPE and effectively limited FV3 replication, demonstrating that regardless of 
how immunoevasive FV3 is known to be, it is unable to break an antiviral program (Chapter 
3). My studies demonstrate that FV3 is capable of eliciting immunoevasion and shutdown of 
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macromolecular synthesis in Xela DS2 and Xela VS2 although the exact mechanism is not 
well understood. It is currently believed that part of this suppression is due to the 
overabundance of viral transcripts which outcompete host transcripts in protein production 
(Jancovich et al., 2015). As such, treatment of Xela DS2 and Xela VS2 with poly(I:C) 
following FV3 infection should be explored to see whether these cells are then able to 
overcome FV3’s immunoevasive strategies. Theoretically, post-treatment wtih poly(I:C) will 
upregulate Xela DS2 and Xela VS2 proinflammatory and antiviral gene expression, 
potentially mitigation the competition between viral and host transcripts dependent on the 
kinetics of the isolated system. So, while immediate FV3 CPE and replication may occur, it 
is assumed that post-treatment will allow for recovery of FV3-induced CPE and still limit, 
but not necessarily eliminate, FV3 replication. This phenomenon should be further 
investigated to better understand the in vitro FV3-frog skin epithelial cell model so that 
future preventative measures on mitigating FV3 infection in vivo can be explored. 
4.5.4. Comparison of Xela DS2 and Xela VS2 to primary skin epithelial cells 
My findings are insightful for better understanding the role of isolated frog skin 
epithelial cells in FV3 infection, however while cell lines can be predictive of in vivo 
mechanisms, they are not necessarily indicative. It is common for cell lines to undergo 
genetic changes over time which go unnoticed, potentiating inconsistency in results 
dependent on the passage range used (Kaur and Dufour, 2012). Although similarities may be 
carried over across passages, any differences must be kept into consideration when making 
conclusions. As such, it would be important to compare the FV3-frog skin epithelial cell 
interaction in Xela DS2 and Xela VS2 to that of primary frog skin cultures alongside other 
properties, such as expression of molecular markers and response to dsRNA.  
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4.5.5. Evaluating the impacts of environmental stress on the ability of Xela DS2 
and Xela VS2 to initiate antiviral and proinflammatory programs 
Xela DS2 and Xela VS2 can be used as an in vitro tool for the screening of 
environmental factors or agents that can influence frog skin epithelial cell immunity, with 
focus on susceptibility to FV3. These include anthropogenic stressors such as chemical 
contaminants from agents like pesticides or fertilizers, and environmental impacts due to 
climate change such as increased global temperatures and decreased dissolved oxygen levels 
in aquatic communities. The presence of chemical contaminants may impair immunity and 
can reduce chemical skin defences (Davidson et al., 2007; Gilbertson et al., 2003). Compared 
to mammalian skin, frog skin has significantly greater uptake potential of xenobiotics that 
can bioconcentrate and may be detrimental to frog health (Blaustein et al., 2003; Quaranta et 
al., 2009; Van Meter et al., 2014). Chemical contaminants can also impact host immune 
function resulting in altered host resistance to pathogens. Exposure to pesticides, such as 
atrazine, has been shown to influence antiviral immunity in larval and adult frogs that led to 
increased susceptibility to FV3 invasion and susceptibility (De Jesús Andino et al., 2017; 
Pochini and Hoverman, 2017; Sifkarovski et al., 2014), which should be further investigated 
in Xela DS2 and Xela VS2. Xela DS2 and Xela VS2 are suitable in vitro models for 
performing wide-scale toxicity screening to monitor the effects of chemical contaminants, 
individually and in tandem, on frog skin epithelial cells. 
Effects due to climate change are already predicted to be drastic where over the next 
century, global average annual temperatures are projected to rise 1.1-6.4°C by 2100 and the 
magnitude and frequency of extreme weather events is also projected to increase (Field et al., 
2012; Lawler et al., 2009; Solomon et al., 2007). As a physiological system, the immune 
system in frogs may be impacted by changes in temperature outside of the hosts’ thermal 
125 
 
optimum, yielding altered immune functions as observed in mammalian and fish models 
(Abram et al., 2017; Bouma et al., 2010). While it was shown that Xela DS2 and Xela VS2 
are capable of supporting growth in across a wide range of temperatures (Chapter 2), the 
ability for these cells to recognize and respond to an immunostimulant at different 
temperatures should be explored. Furthermore, pathogens are also temperature dependent, 
wherein the optimal temperature for FV3 replication is 29°C and incubation at 37°C renders 
FV3 non-permissive (Tripier et al., 1977). While my data show that Xela DS2 and Xela VS2 
are permissive to FV3 infection at 26°C, two possible outcomes are possible when 
considering temperature changes: (a) at lower temperatures, Xela DS2 and Xela VS2 may be 
immunosuppressed thus increasing FV3 susceptibility at MOIs ≤ 0.002, or (b) at higher 
temperatures, such as the FV3 replication optimum of 29°C, may too demonstrate heightened 
susceptibility of frog skin epithelial cells to infection. FV3 susceptibility of Xela DS2 and 
Xela VS2 in changing temperatures should be investigated, as long-term changes in climate 
patterns may contribute to a compromised immune response in the frog host, leading to 
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Appendix D – Sequence confirmation of antiviral and proinflammatory genes 
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